A Study on Azhal Keel Vayu (அழல் கீல் வாயு) by Anusha, D
A STUDY ON 
 
 
AZHAL KEEL VAYU 
 
Dissertation Submitted To 
 
THE TAMIL NADU DR.M.G.R Medical University 
 
Chennai – 32 
 
For the Partial fulfillment for The Award of Degree of 
 
DOCTOR OF MEDICINE (SIDDHA) 
 
(Branch – III, SIRAPPU MARUTHUVAM) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
Government Siddha Medical College 
 
Palayamkottai – 627 002 
 
September - 2008 
ACKNOWLEDGEMENT 
 
 First of all the author take this opportunity to express my gratitude to the 
Vice-chancellor, The Tamil Nadu Dr. M.G.R. Medical University, Chennai and 
The Commissioner, the Commissionarate of Indian Medicine and 
Homeopathy, Chennai who flagged my dissertation with cheer. 
 
 The author would also like to thank Dr. Thinakaran M.D.(S), 
Principal, Dr. Devarajan M.D(S), Palayamkottai for giving me permission 
for my dissertation and to make use of the facilities available in this institution 
to bring out the dissertation a successful one. 
 
The author owe her special gratitude to  Dr. K. SomasekaranB.Sc, 
B.I.M, M.D.(S), Head of the Department, Post graduate Department of 
Sirappu Maruthuvam Branch who stands like a pillar behind all my efforts 
with very pleasure.  The author hereby vote her hearty thanks for his obvious 
directions in all aspects for completion of this work. 
 
The author sincerely expressed her whole hearted thanks to                           
Dr.K. Saibudeen M.D(S), Assistant Lecturer Post graduate Department of 
Sirappu Maruthuvam Branch for their valuable guidance and encouragement 
in this work. 
 
The author extremely thankful to Dr. S. Ramaguru B.Sc., 
M.S.(Ortho), D. Ortho., part-time Professor of Orthopedics, Government 
Siddha Medical College for his valuable guidance in this study. 
 
The author express her deep sense of gratitude to Dr. S. Bagirathi 
MBBS., Medical Officer, Post Graduate Clinical laboratory, Government 
Siddha Medical College, palayamkottai for rendering her, suggestion and 
advices whenever needed. 
 
 The author wish to pay my sincere thanks to Mr. Kalaivanan, Head of 
the Department of Pharmaccology and Mrs. Nagaprema M.Sc., M.Phil, 
Head of the Department of Biochemistry, Government Siddha Medical 
College,Palayamkottai. 
 
The author her sincere thanks to Dr. Padma M.B.B.S., DMRD., Department 
of Radiology, Government Siddha Medical College, Palayamkottai. 
 
The author wish to thank the technical experts of PG Clinical laboratory, 
Radiology, Pharmacology and Biochemistry Departments for their active 
involvement and cooperation. 
 
The author express her gratitude to our librarian, Mrs. Poongodi M.A., 
B.LIB.,  Government Siddha Medical College, for for fetching books for 
reference whenever required. 
 
The author lastly but not leastly acknowledged the timely help rendered 
by Broad Band Net Café, Palayamkottai for bringing this dissertation work in 
a colourful manner. 
  
The author have to thank all her colleagues and friends for assisting and 
helping one in many ways. 
 
Concludingly if, the author d’nt tell her thanks to her parents, this work 
is not fulfilled, for this success of this work.   
 
 
 
 
 
 
 
 
 
 
1 
 
INTRODUCTION 
 Medical science was born since the day man was born.  Through his 
experience, he had learnt about mysteries of his own body, the interrelationship 
between his body and mind.  Then he thought about what would keep his body 
and mind fit.  Now-a-days medical science is tremendously expanding with the 
advancement of time. 
 Every ancient civilization has its own system of Medicine during their 
culture.  In our country, the Indian system of medicine consists of Siddha and 
Ayurvedha.  Siddha belongs to South India especially Tamilnadu.  Siddha 
system of Medicine was gifted by Siddhars, the people with tremendous 
supernatural powers. 
 The basic principles of this system are Ninety Six Thathuvams. Of these 
the “Panchabootha” and “tridosha” theories are most important.  Diseases are 
diagnosed on the basis of the trodosha theory and by Naadi. 
 According to this theory, the physiological function of human body is 
regulated by the three vital humours namely Vatham, Pitham and Kabam.  
Derangement of these three doshas causes the disease as stated by 
Thiruvalluvar. 
 ‘kpfpDk; FiwapDk; Neha; nra;Ak; E}Nyhh; 
 tspKjyh vz;zpa %d;W.” 
 Siddhars are not only scientists, they are also social reformers, 
physicians and chemists.  They heal, cure and solve the human problems by 
their “Supernatural power” called “Siddhi”.  One who attained Siddhi is called 
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“Siddhar”.  Intellectual and spiritual faculties combined with devine (dwine) 
aspects. 
 The mind, soul and the body have to have the absolute co-ordination for 
keeping the health intact.  Mental health is necessary for physical well being.  
That’s why the popular Tamil saint Agathiyar says, 
 ‘kdkJ nrk;ikahdhy; ke;jpuQ; nrgpf;fNtz;lh 
 kdkJ nrk;ikahdhy; thAit cah;j;jNtz;lh 
 kdkJ nrk;ikahdhy; thrpia epWj;jNtz;lh 
 kdkJ nrk;ikahdhy; ke;jpuQ; nrk;ikahNk” 
 The Siddha system of medicine is not only curative and  also possess 
Preventive, rehabilitation and rejenuvation aspects of its  own kind, than other 
systems of Medicine in World.  That is the speciality of our Sirappu 
Maruthuvam Department.  In this, we are studying especially preventive, 
rehabitative and rejenuvative procedures along with Varmam, Enbumurivu, 
Thokkanam, Thol noigal etc.,. 
SIRAPPU MARUTHUVAM 
 Sirappu Maruthuvam is a special branch of siddha medicine that deals 
with the study of  
1. Yoga and kayakalpam 
2. Rejenuvation therapy 
3. Muppu 
4. Varmam, Thokkanam and Enbu murivu 
5. Kirigai. 
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Yoga and Kayakalpam 
 Yoga means union of the individual soul (Jeevatma) and the supreme 
soul (paramatma).  The eight types of yoga are quoted in Thirumanthiram as 
follows 
 ‘,ak epakNk vz;zpyh – Mjdk; 
  eaKW gpuhzh ahkk; gpuj;jpahfhuk; 
   rakpF jhuid jpahdk; rkhjp 
  maKWk; ml;lhq;f khtJ khNk” 
- jpU%yh; jpUke;jpuk; 
1. Iyama       5. Prathyakara 
2. Niyama   6. Dharana 
3. Asanas   7. Thiyana 
4. Pranayama   8. Samadhi. 
 
Thokkanam 
 Thokkanam a kind of  treatment, as a massage like, applied to the 
patient with medicated oil or without oil applying only by trained massager.  
Thokkanam or physio therapy basically used in all vatha diseases and also in 
pitha and kapha diseases.  It eliminates the toxic wastes if accumulated in the 
body.  It nourishes and normalizes the muscles, blood and the skin in a normal 
physiological condition.  Every siddha people is very proud of this procedure 
by appreciated progress. 
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Kirigai 
 Azhal humour may predominate it plays a major role for psychiatric 
development by affecting the other kutram viz vatha and kapha. 
Kaya kalpha (Rejenuvating therapy or Panacea) 
 The Siddhars developed a discipline for all the human beings called 
kaya kalpa designed for longevity as well as get rid of diseases.  The kaya 
kalpa drugs are said to prevent not only degenerated condition but also 
rejenuvate individual’s normal healthy life.  If it is to be practiced day to day, 
disease never occurs. 
Muppu 
 ‘Kg;G njhl;L fw;gKz;L mwpahjhh;f;F 
  vg;NghJk; fhyd; vkd; ” 
- Njiuah;  
Muppu is an important medicine in siddha system of medicine.  It is an 
universal solvent which represents via water, air and fire.  It is useful for 
rejenuvation. 
Fracture 
 It is possible to treat anytype of bone fracture followed by injury or 
trauma or pathological changes.  By applying medicated oils like vasavennai 
the nerve can be activated in order to avoid the fracture complication of the 
atrophy or dysfunction of nerve if left untreated. 
Yoga 
Yoga is one of India’s wonderful gifts by our ancient yogis to mankind.  
One of its valuable qualities is that it builds up a store of physical health and 
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mental health through the practice of a system of exercises called asanas which 
keep the body cleansed and fit. Yoga believes that exercise is essential for 
speedy removal of toxins & for keeping blood circulation and all internal 
processes functioning smoothly. 
Having dealt with the physicalside of life, yoga turns to the mental.  
Here different breathing exercises or techniques quieten the mind & brain, 
offering inner peace and an ability to face upheavals and deal with problems. 
Uniting both these aspects is the philosophy of yoga which has stood the 
test of time, bidding humanity to review its thinking and its conduct, and to 
turn away from violence, dishonesty and greed – a review of life much needed 
in the present day. 
Yoga therefore has a role both in everyday practical life, and in the more 
thoughtful, idealistic scheme of things.  Its value needs to be experienced and 
savoured.  
The word yoga comes from the Sanskrit root “yuj” meaning to join or 
yoke, implying the  integration (or joining) of every aspect of a human being 
from the inner most to the external.  Another frequently used definition of yoga 
is that of union of individual spirit with the universal, since that is its highest 
aim.  A whole doctrine attaches to the postural and breathing aspects of yoga.  
The parallel western concept of ‘mens sana in corpore sano’ –a healthy body in 
a healthy mind – has always been recognized and is finding increasing 
emphasis today. 
6 
 
According to Patanjali, yoga consists of eight limbs, which are all 
equally important and are related as parts of a whole.  They are as follows. 
1. Five universalcommandments (Iyama) : aimed at creating a 
‘better’ world; not harming anyone or anything; truthfulness; non-
stealing; leading a godly, chaste life and being non-grasping. 
2. Five personal disciplines (Niyama) : cleanliness, contentendness, 
self-discipline, self sgtudy and study of the scriptures and dedication 
to God. 
3. Practice of postures (Asana) : devoted and conscientious practice 
of the various types of posture. 
4. Practice of breath control (Pranayama) : pratising breathing 
techniques with care and discrimination. 
5. Detachment from worldly activities (Pratyahara) : Developing a 
non-attached attitude of body and mind. 
6. Concentration (Dharana) : Being able to hold on to a subject 
mentally. 
7. Meditation (Dhyana) : developing a quiet meditative state. 
8. Transconciousness a state of bl.iss (Samadhi) : 
  Reaching a state of absorption in a subject or in the Divine. 
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AIM AND OBJECTIVES 
 The disease “Azhal Keel Vayu” is a major ailment of the elderly.  This 
produces pain and discomfort to the patients.  The purpose of author’s work is 
to elucidate a good medicine from ancient Siddha literatures and to create hope 
and faith in their treatment.  Their being a preliminary endeavour by the author, 
as if it would be a helping hand to the sufferers.  With this view this 
dissertation subject was undertaken. 
 1. To prove the efficacy of our Siddha Medicine to the world. 
2. To study the clinical cause of the disease “Azhal Keel Vayu” 
with keen observation on the Aetiology, Pathology, Diagnosis, 
Prognosis, Complications and the Treatment by making use of 
Siddha aspect. 
3. To expose the unique diagnostic methods mentioned by Siddhars, 
to know the disease “Azhal Keel Vayu” alters the normal 
condition under the topic Mukkutram, Poripulangal, Ezhu Udal 
Kattukkal and Envagai thervugal. 
4. To know the extent of correlation of Aetiology, Classification, 
Signs and Symptoms of Azhal Keel Vayu in Siddha aspect with 
Osteo arthritis in Modern medicine. 
5. To have an idea about the incidence of the disease with age, sex, 
socio-economic status and climatic conditions. 
6. To have a detailed clinical investigations. 
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7. To have a clinical trial on Azhal Keel Vayu tha author has given 
the drug named Keelvathathuku Choornam as internal 
medicine and Keelvathathuku thylam as external medicine. 
8. To evaluate the Bio-chemical and Pharmacological effects of trial 
medicine. 
9. To use modern parameters to confirm the diagnosis and prognosis 
of the disease. 
10. To insist Thokkanam (Massage) and Asanas along with 
medicines to achieve the good results.  
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SIDDHA LITERATURE 
 
  
         ‘mz;lj;jp Ys;sNj gpz;lk; 
  gpz;lj;jp Ys;sNj mz;lk; 
  mz;lKk; gpz;lKk; xd;Nw 
  mwpe;J jhd; ghh;f;Fk; NghNj” 
- rl;l Kdp Qhdk; 
kdpj clk;ngd;gJ mz;lj;jpDila RUf;fkhFk;.  ,e;j 
gpugQ;rk; gQ;r g+jq;fshyhdJ. 
mit 
1. kz; (Solid) 
2. ePh; (Fluid) 
3. jP (Radiance) 
4. tsp (Air) 
5. Mfhak; (Ether) 
kdpjDila clw;$Wfs;> cly; ,aq;fpay;> Neha;f; fhuzq;fs;> 
czT> kUe;Jfs; Mfpa midj;Jk; gQ;r g+jq;fshy; Mf;fg;gl;lJ. 
kdpj clk;gpw;F ePh;> tsp> jP Mfpa 3 g+jq;fSk; Kf;fpa 
MjhukhFk;.  ,itNa Kf;Fw;wk; vd;W toq;fg;gLfpwJ. 
  tsp  - ,lfiy + mghdd; 
  moy;- gpq;fiy + gpuhdd; 
  Iak; - ROKid + rkhdd; 
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mz;lk;> gpz;lk; ,uz;ilAk; ,izg;gJ Kf;Fw;wkhFk;.  ,JNt 
gpz;lj;ij rPuhf nray;gl itf;fpfpwJ.  ,e;j Kf;Fw;w epiyfspy; 
khw;wk; Vw;gLk; Ntisapy; clypy; Ffuz khw;wq;fsha; ntspg;gLk;. 
 
 ’kpfpDk; FiwapDk; Neha;nra;Ak; E}Nyhh;  
  tsp Kjyh vz;zpa %d;W” 
- jpUf;Fws; 
njd; ,e;jpa czT fyhr;rhuj;jpy; mWRitfs; $wg;gLfpwJ.  mit
  
1. ,dpg;G (Sweet) 
2. Gspg;G (Sour) 
3. cg;G (Salt)  
4. ifg;G (Bitter) 
5. fhh;g;G (Pungent) 
6. Jth;g;G (Astringent) 
 
,U g+jq;fspd; Nrh;f;ifNa RitahFk;. 
  1. ,dpg;G - kz; + ePh; 
  2. Gspg;G   -  kz; + jP 
  3. cg;G - ePh; + jP 
  4. ifg;G  - fhw;W + Mfhak; 
  5. fhh;g;G  - fhw;W + jP 
  6. Jth;g;G  -  kz; + fhw;W 
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 Rit> Kf;Fw;wk;> Ik;g+jq;fs; ,it %d;Wk; rpj;j kUj;Jtj;jpd; 
mbg;gilj; jj;Jtq;fshFk;. 
tsp> moy;> Iak; ,it %d;Wk; 1> ½> ¼ vd;w khj;jpiu mstpy; 
,ay;ghf toq;fg;gLfpwJ.  ,itfspd; khw;wNk Neha; 
FwpFzq;fshFk;. 
 
       ‘toq;fpa thjk; khj;jpiu nahd;whfpy; 
 joq;fpa gpj;je; jd;dpyiu thrp 
 moq;Fq; fge;jhdlq;fpNa fhNyhby; 
 gpwq;fpa rPth;f;F gprnfhd;W kpy;iyNa” 
- Fzthflk; 
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moy; fPy; thA 
 
rpj;j kUj;Jtj;jpy; vz;gJ tif tsp Neha;fs; gw;wp 
$wg;gl;Ls;sJ.  moy; fPy; thA vd;gJ> fPy;thA vd;w jiyg;gpd; fPo; 
$wg;gl;l gj;J tiffSs; xd;W.  fPy;thA vd;gJ %l;Lfspy; Vw;gLk; 
Neha;fis Fwpg;gjhFk;. 
 
NtW ngah;fs;: 
re;Jtyp> %l;Ltyp> Nkf#iy> Klf;F thA> Mkthjk;> re;J 
thjk;> #iyfl;L> re;jpf rpNy\;k Nuhfk;> thj#iy> thANuhfk;. 
 
fhuz ngah;fs;: 
Neha; fhuzk;    -   Nkf #iy 
Kf;Fw;w epiy khWghL    -   thj #iy 
          re;jpf rpNy\;k Nuhfk; 
          re;J thjk; 
,lj;ij nfhz;L    -    %l;L typ 
       re;J typ 
       Mk thjk; 
FwpFzq;fis nfhz;L   -    #iyfl;L 
           Klf;Fthjk; 
Neha; ,ay;: 
fPy;thA vd;Dk; tsp NehahdJ typ> tPf;fk;> Fj;jy;> %l;Lfis 
mirf;f rpukk;> tpiwg;Gj;jd;ik> Ruk;> grpapd;ik> Nrhif Mfpa 
FwpFzq;fis cilajhFk;. 
13 
 
Neha; tiffs;: 
1. tsp fPy; thA 
2. moy; fPy; thA 
3. Ia fPy; thA 
4. tsp moy; fPy; thA 
5. moy; tsp; fPy; thA 
6. tsp Ia fPy; thA 
7. moy; Ia fPy; thA 
8. Ia tsp fPy; thA 
9. Ia moy; fPy; thA 
10. Kf;Fw;w fPy; thA 
 
Neha; tUk; top 
czT> gof;ftof;fq;fs;> Rw;Wg;Gw #o;epiy Mfpait 
Kf;Fw;wj;jpy; khWghL Vw;gLj;jp Nehia cz;lhf;FfpwJ. 
 
Rw;Wg;Gw #o;epiy: 
 
        ‘thj th;j;jd fhyNkNjh ntd;dpy; 
  kUTfpd;w Mdp fw;fl khjk; 
  Mjidg; grpNahL fhh;j;jpif jd;dpy; 
  mlUNk kw;w khjq;fs; jd;dpy; 
  NghfNt rkpf;fpd;w fhykhFk;” 
- a+fp rpe;jhkzp 
tsp NehahdJ Mdp Kjy; fhh;j;jpif khjq;fspy; mjpfkhff; 
fhzg;gLk;. 
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‘gJkj;ijg; g+f;f itf;Fk; ghDkpf;f fhAk; 
KJNtdp ypw;G tpw; ePh; Kw;Wk; - fJnkd 
tw;Wk; fgk‡Fk; thAkpFk; tho;khe;jh;f;  
  Fw;w eypf; Nfjpnjd; NwhJ” 
- rpj;j kUj;Jthq;f RUf;fk; 
KJNtdpw; fhyj;jpy;> #hpa ntg;gj;jpd; fhuzkhf ngUk; 
thhpahf ePh; Mtpahf;fg;gl;L G+kpapy; twl;rp epyTk;.  mJNghy; ekJ 
clypy; twl;rp Vw;gl;L tspNeha; tUtjw;F VJthfpwJ. 
 
czT: 
 
   ‘tspjU fha; fpoq;F tiutpyh japyy; Nfhio 
    Kspjaph; Nghd;kpFf;F Kiwapyh Tz;b Nfhly; 
    Fsph;jU tspapw; Nwfq; Fdpg;Gw Tyty; ngz;bh; 
    FspjU kaf;fk; ngw;Nwhh; fbnray; fUtpahkhy;” 
- rghgjp ifNaL 
 
thj Fw;wj;ij kpifg;gLj;jf;$ba fpoq;F tiffs;> Fsph;r;rpia 
juf;$ba gjhh;j;jq;fs; kpFjpahf cz;zy;> Fsph;e;j fhw;wpy; ,Uj;jy;> 
kioapy; eidjy;> gdpf;fhw;W NkNy tpOjy;> kiyg; gpuNjrq;fspy; 
trpj;jy; kw;Wk; guk;giuapd; fhuzkhfTk; Njhd;Wk;. 
‘njhopy;ngW ifg;Gf; fhh;j;jy;> Jth;j;jy; tpQ;RfpDQ; NrhWk; 
  gioajhk; tuF kw;iwg; ige;jpid aUe;jpdhYk; 
  vopy; ngwg; gfYwq;fp ,utpdpYwq;fhjjhYk; 
  kio epfh; FoypdhNy thjq;Nfh gpf;Fq;fhNz” 
- guuhr Nrfuk; 
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ifg;G> Jth;g;G> fhh;g;G gjhh;j;jq;fis kpFjpahf cz;zy;> gioa 
NrhW> tuF> jpid cz;zy;> gfypy; cwq;fp ,utpy; tpopj;jpUj;jy; 
Mfpa fhuzq;fspdhYk; thjk; kpFgLk;. 
 
gof;f tof;fq;fs; 
‘nta;apypy; elf;ifahYk; kpfj; jz;zPh; Fbf;ifahYk; 
nra;apio kfspiur; Nrh;e;jD gtpf;ifahYk; 
igaNd cz;ikahYk; ghfw;fha; jpd;ifahYk; 
ijaNy thjNuhfk; rdpf;Fnkd; wwpe;Jnfhs;Ns” 
- Njiuah; thflk; 
#hpa ntg;gj;jpy; mjpf njhiyT elf;ifahYk;> mjpf jz;zPh; 
Fbj;jyhYk;> mjpfsT ghfw;fha; cz;ZtjhYk; mjpfsT fhkk; 
Ja;g;gjhYk; tsp Neha; Vw;gLk;. 
 
‘fhzNt kpfTz;lhYq; fUJgl;bdp tpl;lhYk; 
 khd;idahh; fz; Nkhfkwf;fpD kpFe;jpl;lhYk; 
 Mzt kyq;flk;ik aq;qNd tplhjjhYk; 
 thDjd; kley; yhNs thjq;Nfh gpf;Fq;fhNd” 
- guuhr Nrfuk; 
mjpf msT cz;zy;> gl;bdp fplj;jy;> Mztk; mjpfhpj;jy; 
Mfpatw;whYk;> 
‘ghhpdpw; gag;gl;lhYk; gyUld; Nfhgpj;jhYk; 
fhnudf; fUjpNahbf; fOkuj; Juj;jpdhYk; 
Vh;ngW jdJ neQ;rpd; kpfj; Jf;fkile;jpl;lhYk; 
ghhpa fhw;wpdhYk; glhpDk; thjq;fhZk;”. 
guuhr Nrfuk; 
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        gak;> vy;NyhhplKk; Nfhgk; nfhs;sy;> kpFjpahf xly;> kpFe;j 
Jf;fk;> jpdKk; clypd;Nky; fhw;Wg;gly; Nghd;wtw;whYk;> 
 ‘fhyq;fz; khwpAz;Zq; fhhpaj; jhYe ;jz;zPh; 
 rhyNt aUe;jpdhYe; re;jpYl; fhh;e;jhYk; 
 Nfhykhk; Gspg;G nea;ia tUe;jpdhYk; 
 thy;thh; Kiy ey;yhNs thj Kw;gtpf;Fq;fhNz” 
- guuhr Nrfuk; 
‘$Wnkhd;W %d;Wld; FyT ehiye; NjopYk; 
  Fw;wkhk; eyj;jpDk; nfh^uk; gd;dpuz;bYk;  
  NruNt Gjd;jhWNkh rPhpaNkid epd;wpby;  
  nrg;nghzhj jPikNahL nra;Ak; gr;re;jhWk; 
  neLe;Jf;f kpf;fthk; elf;fe;jhJ njhopy; jhk; 
  epe;ijahF fPy;gpbg;G ePL nka;apy; Njhd;Wkhk; 
   fhhpaq;fs; Nrjkha; fhy;taJ FiwAkhk; 
  fz;Lzh;e;J fzpj ty;Nyhd; fUj;Jld; nrg;gpdNu.” 
- kzpke;jpu itj;jpa Nrfuk;. 
‘vd;dNt thjk; jhndz;gjhFk;  
 ,fj;jpNy kdpjh;fSf;F nra;AthW 
 gpd;dNt nghd;jidNa Nrhuq;nra;J> 
 nghpNahh;fs; gpuhkziuj; J}~zpj;Jk;> 
 td;Njtw; nrhj;jpr; NrhuQ; nra;J  
 khjh gpjh FUit kwe;j Ngh;f;Fk; 
 fd;dNt Ntfj;ij epe;ij nra;jy; 
 fhaj;jpy; fye;jpLNk thje;jhNd” 
A+fp rpe;jhkzp ghly; 243 
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‘jhndd;w frg;NghL Jth;Giwg;G  
 rhjfkha; neQ;nrYr; rikj;j tz;zk; 
 Mndd;w thwpdJ nghrpj;jyhYk; 
 Mfhaj; NjwyJ Fbj;jyhYk; 
  ghndd;w gfYuf;f kpuhtpopg;G 
 gl;bdpNa kpfAWjy; ghunka;jy; 
 Njndd;w nkhopahh;Nks; rpe;ijahjy; 
 rPf;fpukha; thjkJ nrdpf;Fe;jhNd” 
- A+fp rpe;jhkzp ghly; 244 
jha;> je;ij> FU> ,th;fis kwj;jy;> Ntjj;ijg; gopj;jy;> frg;G> 
Jth;g;G> ciug;G Nrh;e;j czit mUe;jy;> Mwpd czit cz;zy;> 
Njq;fpa ePh;> yhfphpahd fs;> rhuhak; Fbj;jy;> gfypy; J}q;fp ,utpy; 
tpopj;jpUj;jy;> mjpfkhf gl;bdp fplj;jy;> kpFe;j Rikiaj; J}f;Fjy;> 
ngz;zpd; Nky; rjh epidg;Gf; nfhs;sy; Mfpa fhuzq;fshy; thj 
Neha; cz;lhFk;. 
 ‘tspAaike; jd;dpiy nfl;L 
 typAld; tPf;fr; RuKk; fha;e;J 
 %l;Lfs; NjhWk; KLf;fpNa nehe;J 
 %l;Lfs; jd;dpy; ePUk; Rue;J 
 jhq;nfhzh typAkh nehe;jpLkk;Nk” 
- rghgjp ifNaL 
thjKk;> fgKk; jd;dpiyf; nfLtjhy; %l;Lfspy; typ tPf;fk;> 
ePh;Nfhh;j;jy; Mfpait gpwf;fpd;wd. 
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‘E}nyd;w thjk; te;j tifjhNdJ 
 jd;ikaha;f; fd;kj;jpd; tifiaf; NfS 
 fhypNy Njhd;wpaJ fLg;gNjJ 
 iffhypy; Klf;fpaJ tPf;fNkJ 
 NfhypNy gLfpd;w tpUl;rkhd 
 Foe;ij kue;jid ntl;ly; Nky;Njhy; rPty; 
 ehypNy rPtIe;J fhy; Kwpj;jy; 
 ey;ynfhk;G jioKwpj;jy; eypj;jy; jhNd” 
     - mfj;jah; fd;kfhz;lk; 
thj Neha;f;fhd ,ay;G 
 ‘thjNk fjpj;jNghJ thATnkOk;Gq; fz;Bh; 
   thjNk fjpj;jNghJ te;jpLQ; rd;dp Njh\k; 
   thjNk fjpj;jNghJ ty;Yld; nkype;J nfhy;Yk;” 
- mfj;jpah; rpfpr;rhuj;d jPgk; 
thjk; kpFe;jNghJ thA kpFk;> rd;dp Njhlk; Nghd;w gy 
tpahjpfs; te;J NrUk;> cly; nkypAk;. 
 
        ‘thjtPW md;dkpwq;fhJ fLg;Gz;lhk; tz;zKz;lhk; 
 NkhJfl;F Nuhfk; RuKz;lh kpUkYkh Kwq;fhnjd;Wk; 
 XJjhpa thjkdyhF eLf;fKz;lhk; nghUs; fsah;e;j 
 jPnjdNt euk;gpj;J re;Jfs; NjhWq;fLf;Fe; jpdKe;jhNd” 
- Njiuah; thflk; 
thjk; kpFk;NghJ grpapd;ik> cly; fLg;G> Ruk;> ,Uky;> 
cwf;fkpd;ik> cly; eLf;fk;> euk;Gj;jsh;r;rp> re;Jfs; NjhWk; Filjy; 
Nghd;w FwpFzq;fs; Njhd;Wk;. 
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‘jf;f thA Nfhgpj;jhy; re;Jise;J #iyNehth  
   kpf;f nfhl;lhtp tpl;lq; nfhpA kyq;nfl;Lk; 
   xf;f euk;G jhd; Klq;F kyh;e;J tha; eP&wptUk; 
   kpf;f FspUk; eLf;fkha; Nkdp Fd;wp tUq;fhNd” 
- Njiuah; thflk; 
thjk; kpFk;NghJ %l;Lfspy; typ> kpFe;j nfhl;lhtp> kyr;rpf;fy;> 
euk;Gj;jsh;r;rp> tha; ePUwy;> kpff;Fsph;r;rp> cly; eLq;fy; Nghd;w 
FwpFzq;fs; Njhd;Wk;.  
 
moy;fPy; thA 
Neha; FwpFzq;fs;  
‘gpj;j fPy;thA jd;dhw; fPy;%l;L tPq;fpr; 
rpj;jh; nra; kUj;Jtr; rPh;glhjd;ikj;jhfp 
jj;jW fha;r;ry; fz;L rhyNt jidjhd; je;Nj 
nkj;jw rpfpr;ir jd;dhy; nkd;Nky; ePf;Fkg;gh” 
- rghgjp ifNaL. 
Kf;Fw;wk; 
thjk; - thA> twl;rp> typ> ke;jk;> ,yF Mfpa jd;ikfis 
cilaJ. 
gpj;jk; - ntg;gk;> $h;ik> nea;g;G> nefpo;r;rp>,af;fk; Mfpa jd;ikfis 
cilaJ. 
fgk; - jd;ik> nea;g;G> ke;jk;> tOtOg;G> nkd;ik> jpz;ik Mfpa 
jd;ikfis cilaJ. 
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thjk;: 
thjk; thOkplk; 
 mghdd; 
 kyk; 
 ,lfiy 
 ce;jpapd; fPo;%yk; 
 ,Lg;G 
 vYk;G 
 Njhy; 
 euk;Gf;$l;lk; 
 fPy;fs; 
 kaph;f;fhy; 
 Cd; 
thjj;jpd; ,aw;if gz;G 
 Cf;fKz;lhf;fy; 
 %r;R tply;> thq;fy; 
 kdnkhopnka;fSf;Fr; nraiyj;juy; 
 kyk; Kjypa gjpdhd;F tpiuTfis ntspg;gLj;jy; 
 rhuk; Kjypa VO clw;fl;Lfl;Fk; xj;j epfo;r;rpiaj; juy; 
 Ik;nghwpfl;F td;ikiaf; nfhLj;jy; 
thjk;-clypy; nra;njhopy;: 
 cly; Nehjy; 
 Fj;jy; 
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 gpsj;jy; Nghy; fhzy; 
 euk;G Kjypad Fd;wy; 
 eLf;fy; 
 ,Uf;fkhjy; 
 ePh;g;girapd;ik 
 mirj;jy; 
 ,isj;jy; 
 Filr;ry; 
 jb Kjypatw;why; mbgl;lJ Nghd;w Ntjid 
 if my;yJ fhy; ,lk; tpl;L ngah;jy; (g+l;L eOty;) 
 cWg;G jsh;r;rp 
 cWg;Gfs; njhopy; Ghpahky; kuk; Nghy; fplj;jy; 
 kyk;> rpWePh; Kjypad jPa;jy; my;yJ milgLjy; 
 ePh;Ntl;if 
 nfz;ilf;fhy;> njhil Kjypad nehWq;fpg; NghtJNghy; 
Njhd;wy; 
 vYk;Gf;Fs; Jisg;gJ Nghd;w czh;r;rp 
 kaph;f;$r;nrwpjy; 
 if> fhy;fis klf;fTk;> ePl;lTk; ,ayhjgb nra;jy; 
 vr;RitAk; Jth;g;gha; ,Uj;jy; my;yJ Jth;g;ghf tha; 
ePUwy; 
 Njhy;> fz;> kyk;> ePh; Kjypad fWj;Jf; fhzy; 
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thjj;jpd; Fzk;: 
 twl;rp (Dry) 
 Fsph;r;rp (Cold) 
 mZj;Jtk; (Subtle) 
 fbdk;  ( Rough) 
 mirjy; (Unstable) 
 ,yF (Light) 
 
thjj;jpd; tiffs;: 
1. gpuhzd; 
%r;R tpLjYk; thq;FjYk; nra;Ak;. 
2. mghdd; 
ky ryj;ij fPo;Nehf;fp js;Sk; 
3. tpahdd; 
clypYs;s mirAk;nghUs;> mirahg;nghUs; vd;Dk; 
,uz;bYkpUe;J cWg;Gfis ePl;lTk; klf;fTk; nra;Ak;. 
4. cjhdd; 
the;jpia vor; nra;Ak; 
5. rkhdd;  
kw;w thAf;fis kpQ;r xl;lhky; nra;Ak; 
6. ehfd; 
vy;yhf; fiyfisAk; fw;Fk;gb mwpit vOg;Gk>; fz;fis 
,ikf;Fk;gb nra;Ak;. 
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7. $h;kd; 
nfhl;lhtp tplr; nra;Ak;> thia %lg; gz;Zk;> ,ikiaf; 
nfhl;Ltpf;Fk;> fz;fSf;F nghUl;fisf; fhz;gpf;Fk;. 
8. fpUfud; 
ehtpw;frpT> ehrpapw;frpT> kpf;f grp> Jk;ky;> ,Uky; Mfpatw;iw 
cz;lhf;Fk;. 
9. Njtjj;jd; 
Nrhk;gy;> rz;ilnfhs;sy;> jh;f;fk; Ngry;> kpf;f Nfhgk; 
Mfpatw;iw cz;lhf;Fk;. 
10. jdQ;nrad; 
clk;G KOikAk; tPq;fg;gz;Zk;> ,we;Jtpbd; fhw;nwy;yhk; 
ntspg;gl;l gpd;dh; %d;whtJ ehspy; jiyntbj;jgpd; ntspr; 
nry;Yk;. 
moy;fPy; thAtpy; tpahdd;> mghdd;> rkhdd; Mfpait 
ghjpg;gile;Js;sJ. 
gpj;jj;jpd; tiffs;: 
1. mdw;gpj;jk; 
cz;lczTg; nghUl;fisr; nrhpf;Fk;gb nra;Ak;. 
2. ,uQ;rfgpj;jk; 
cztpypUe;J gphpe;Jz;lhd rhw;Wf;Fr; nre;epwj;ij jUk;. 
3. rhjf gpj;jk; 
tpUg;gkhd njhopiy nra;J Kbf;Fk;. 
4. gpuhrfk; 
NjhYf;F xspiaf; nfhLf;Fk;. 
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5. MNyhrfk; 
fz;fSf;F nghUs;fisj; njhptpf;Fk;. 
moy;fPy; thAtpy; mdw;gpj;jk;> rhjfgpj;jk; ghjpg;gilAk;. 
 
fgj;jpd; tiffs; 
1. mtyk;gfk; 
ehd;F tif Iaq;fl;Fk; gw;Wf; NfhlhapUf;Fk;. 
2. fpNyjk; 
cz;zg;gl;l czTg;nghUs;> ePh; Kjypaitfis <ug;gLj;jp> 
nkj;njdr; nra;Ak;. 
3. Nghjfk; 
cz;Zfpw Ritfis mwptpf;Fk;. 
4. jw;gfk; 
fz;fSf;F  Fsph;r;rpia jUk;. 
5. re;jpfk; 
g+l;Lfspy; epd;W ,aw;ifaha; vy;yhf; fPy;fisAk; 
xd;Nwhnlhd;W nghUj;jpj; jsur; nra;Ak;. 
moy;fPy; thAtpy; fpNyjk;> re;jpfk; ghjpg;gilAk;. 
VO clw;jhJf;fs;: 
1. rhuk; 
cliyAk;> kdijAk; Cf;fKwr; nra;Ak;. 
2. nre;ePh; 
mwpT> td;ik> xsp> nrUf;F> xyp ,itfis epiyf;fr; nra;Ak;. 
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3. Cd; 
clypd; cUtj;ij mjd; njhopw;fpzq;f mikj;J tsh;f;Fk;. 
4. nfhOg;G 
cWg;GfSf;F nea;g;Gg; gira+l;b fbdkpd;wp ,aq;fr; nra;Ak;. 
5. vYk;G 
nkd;ikahd cWg;Gfis ghJfhj;jy;> cly; mirtpw;F 
mbg;gilahapUj;jy; Mfpatw;iw nra;Ak;. 
6. %is 
vd;Gf;Fs; epiwe;J mitfSf;F td;ikAk;> nkd;ikAk; jUk;. 
7. Rf;fpyk;/RNuhzpjk; 
fUTw;gj;jpf;F JizGhpAk;. 
 
moy;fPy;thAtpy; rhuk;;> nre;ePh;> Cd;> nfhOg;G vd;G 
ghjpg;gilAk;. 
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Kf;Fw;w NtWghL (Pathophysiology of three humours) 
vd;Gk; %l;Lk; thjk; thOkplkhFk;.  Mjyhy; elf;f> Xl thjNk 
fhuzkhfpwJ.  moy;fPy; thAtpy; thjk; ghjpf;fg;gl;L mjdhy; 
tpahdd;> mghdd; ghjpf;fg;gLfpd;wJ.   
tpahdd; ghjpf;fg;gLtjhy; typ> %l;Lfis mirf;f rpukk;> 
mghdd; ghjpf;fg;gLtjhy; kyr;rpf;fy; Mfpad Vw;gLfpwJ. 
thjj;Jld; fgk; (re;jpfk;) ghjpf;fg;gl;L %l;L mirTfspy; 
khw;wk; Vw;gLfpwJ. 
filrpahf gpj;jk; ghjpf;fg;gl;L rhjfkhd gzpfisr; nra;a 
KbahkyhfpwJ. 
fhyepiyfspy; Kf;Fw;wk; (Three doshas in seasonal variation) 
 
KJNtdpw; fhyj;jpy; ekJ clypy; twl;rp Vw;gl;L tspNeha; 
tUtjw;F VJthfpwJ. 
 
 
 
 jd;dpiy 
tsh;r;rp 
Ntw;Wepiy 
tsh;r;rp 
jd;dpiy 
miljy; 
thjk; KJNtdpy; fhh;fhyk; $jph;fhyk; 
gpj;jk; fhh;fhyk; $jph;fhyk; Kd;gdp 
fgk; gpd;gdp ,sNtdpy; KJNtdpy; 
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thjk; kpF Fzk; (Character of Elevated Vatha) 
 
 ‘mwpAk; thjj;jpy; mLj;j gpj;jkhapd; 
   FwpaJjhd; thAk; FoWk; newpahy; 
   FspUq; fhy; tPq;Fk; Fly; Gwl;Lk; tpk;kpj; 
   njsptpy;iy Gj;jpnadr; nrg;G” 
    -fz;Zrhkpak; vd;Dk; itj;jpa Nrfuk; 
‘nrhy;yNt thjkJ kPwpw;whdhy; 
Nrhh;tile;J thAtpdhy; Njfnkq;Fk; 
nky;yNt if fhy;fSf; frjpAz;lhk; 
nka;Klq;Fk; jpkunthz;zhj; jpkpUz;lhk; 
ty;yNt Aly; nghUKk; tapWisf;Fk;  
tpUk;gp ad;dr; nry;yhJ tpe;J e\;lk;  
nfhs;sNt ehg;Gspf;Fk; fopr;rYz;lhk; 
$wpdhh; kiyKdp $wpdhNu”. 
-mfj;jpah; rpfpr;rh uj;d jPgk; 
thjk; kpFk;NghJ cly;nkypT> cly;Nrhh;T> if fhy; mrjp> 
clypy; jpkpUz;lhjy;> tapw;W nghUky;> fopr;ry;> tpe;J e\;lk;> ehit 
Gspf;fr; nra;jy; Nghd;w Fzq;fs; cz;lhFk;. 
 
  ‘mwpatpk; %d;wpd; jd;ik nrhd;dhh;ee;jp 
  vwpa ey;thj nkwpf;Fq; Fzq;NfS 
  Fwpnadf; iffhy; Fisr;R tpyhr;re;J 
  gwpnad nehe;Ekw; gr;ir Gz;zhFNk 
  Gz;zha; typf;Fk; nghUKk; FlNyhbj; 
  jz;zh kyj;ijj; jk;gpf;Fk; Nghf;fhJ 
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  xz;zh MrdKwNt Ruf;fpLk; 
  kz;zhh; Fsph;rPLk; gUj;jpLk; thjNk” 
- jpU%yehadhh; rpfpr;rhuj;djPgk; 
thj Nehapy; cisr;ry;> tpyhr; re;Jfs; Nehjy;> tapW nghUky;> 
Flypiwr;ry;> kyr;rpf;fy; Nghd;w FwpFzq;fs; Njhd;Wk;. 
jpiz (Geographical distribution) 
FwpQ;rp -  kiyAk; kiy rhh;e;j gFjpAk; 
Ky;iy  -   fhLk; fhL rhh;e;j gFjpAk; 
kUjk;   -   taYk; tay; rhh;e;j gFjpAk; 
nea;jy;  -   flYk; fly; rhh;e;j gFjpAk; 
ghiy  -   kzYk; kzy; rhh;e;j gFjpAk; 
Ky;iy kw;Wk; nea;jy; epyq;fspy; thjNeha;fs; ngUkstpy; 
Vw;gLk;. 
cly; td;ik (Body Built) 
1. ,aw;if td;ik- gpwtpapNyNa jUtpg;gJ 
2. fhy td;ik - tajpy; jUtpg;gJ 
3. nraw;if td;ik - czT gof;f tof;fq;fspdhy; jUtpg;gJ 
moy;fPy; thAtpy; czT gof;f tof;fq;fs; kw;Wk; taJ 
Nghd;wit Kf;fpa gq;F tfpf;fpd;wd.  MfNt nraw;if td;ikAk;> 
fhy td;ikAk; ghjpf;fg;gLfpd;wd. 
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Neha; epjhdk; (Differential Diagnosis) 
tspfPy; thA 
jhq;f Kbahj typ> fhy; tpuy;> Koq;fhy; %l;L> ,Lg;G %l;L> 
Koq;if %l;L> Njhs; %l;L Mfpa %l;Lfspy; tPf;fk;> tha; twl;rp> 
Ruk;> jiytyp> glglg;G> kyr;rpf;fy;> tpah;j;jy; Mfpa 
FwpFzq;fisAilajhFk;. 
Iaf;fPy;thA 
%l;Lfspy; jhq;f Kbahj typ> cly; nkypT> grpapd;ik> tpf;fy;> 
the;jp> ghz;L Mfpa FwpFzq;fs; fhl;Lk; NehahFk;. 
tsp IafPy; thA 
%l;Lfspy; typ> tPf;fk;> mirf;f rpukk;> Ruk;> J}f;fkpd;ik> 
Mfpa FwpFzq;fSld; Koq;fhy; %l;by; ehpapd; jiyNghy; tPf;fk; 
fhZk;. 
gpzpawpKiwik (Diagnostic Methods) 
1. nghwpahywpjy; 
2. Gydhywpjy; 
3. tpdhjy; 
vz;tifj; Njh;Tfs; (Diagnostic Parameters) 
‘Neha;ehb Neha;Kjy; ehb mJ jzpf;Fk; 
   tha;ehb tha;g;gr; nray;” 
                                                     -   jpUf;Fws; 
Neha; ehly; - Nehia gw;wpawpjy; 
Neha; Kjdhly; - Neha;f;fhd fhuzq;fis mwpjy; 
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 rpj;jh;fs; clk;G> Neha;> Neha;f; fhuzk; Mfpatw;iwg; gw;wpawpe;J 
Nehia fzpj;Js;sdh;. Neha;f;fhd FwpFzq;fisf; nfhz;L 
fzpj;Js;sdh;.  vz;tifj; Njh;Tfs; %yk; Nehia ehk; vspjhff; 
fzpf;fyhk;. 
1. eh (Tongue) 
2. epwk; (Colour) 
3. nkhop (Speech) 
4. tpop (Eye) 
5. kyk; (Faeces); 
6. %j;jpuk; (Urine) 
7. ehb (Pulse) 
8. ];ghprk; (Touch) 
vz;tifj;Njh;T ghh;f;f Ntz;baJ 
moy;fPy;thAtpy; 
fz;lJ 
1. eh epwk;> jd;ik kh gbe;Js;sJ 
2. epwk; Kf;Fw;w epw khWghL fUg;G - thjk; 
3. nkhop Xyp> jd;ik kpjkhd xyp 
4. tpop epwk;> nray; khw;wkpy;iy 
5. kyk; Kf;Fw;w epw
khWghL jd;ik 
fUg;G thjk; 
kyr;rpf;fy; 
6.%j;jpuk; 
  ePh;f;Fwp 
epwk;> kzk;>vil
vQ;ry; 
khw;wkpy;iy 
  nea;f;Fwp  muntd ePz;lJ 
7. ehb Kf;Fw;w epiy thj gpj;j ehb 
8. ];ghprk; ntg;gk; my;yJ 
Fsph;r;rp 
%l;Lfspy; ntg;gk; 
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ehb 
 ‘gpj;jj;jpy; thjkhfpy; gplhpAq;fhYq;ifAq; 
  Fj;jJ NghNyahFq; FWjp nka;gJWk; gpd;Nd 
  mj;jpahAyUNkdpahf KQ;Ruj;jhy; Nehthk; 
  Gj;jpAkbAkpe;jj; nghWikNgha;f; NfhgkhNk.” 
- mfj;jpah; ehb 
‘jpUj;jkhk; thjj; NjhNl jPq;nfhL gpj;jk; Nrhpw; 
 nghUj;Jfs; NjhWk; nehe;J NghjNu gpbf;Fk;” 
- Nehapd; rhuk; 
‘fhzg;gh thj kPwpy; fhy;iffs; nghUj;jp NehFNk” 
- fhtpaehb. 
‘thjj;jpy; Nrj;Jkkhfpy; typNahL tPf;f Kz;lhk;” 
- mfj;jpah; ehb 
‘mwpe;Jghh; thjNk jdpj;jhdhy; 
rhpe;jplNt fhy; Klf;Fk;” 
- mfj;jpah; ,uj;jpdr; RUf;fk; 
kUj;Jtk; 
jd;dpiy jphpe;j thj Fw;wj;ij jd;dpiyg;gLj;j Ntz;Lk;. 
‘tpNurdj;jhy; thje;jhOk;” 
 15 kpyp nts;is vz;nza; fhiy kl;Lk; ntWk; tapw;wpy; 
nfhLf;f Ntz;Lk;. 
kUe;J nfhLf;f Muk;gpf;Fk;Kd; Kjy; ehs; tpNurdj;jpw;F 
xUKiw kl;Lk; nfhLj;J kWehs; Kjy; Ma;Tf;F 
vLj;Jf;nfhs;sg;gl;lkUe;J nfhLf;f Ntz;Lk;. 
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1. fPy;thjj;Jf;F #uzk; - 2 fpuhk; ,UNtis fhiy kw;Wk; ,uT 
czTf;Fg; gpd; ghypy; fye;J rhg;gpl Ntz;Lk;. 
2. fPy;thjj;Jf;F ijyk; - ntspg;gpuNahfk; 
 
gj;jpak; (Dietary Restrictions) 
,r;rh gj;jpaj;jpy; ePf;Fk; nghUs;fs;: 
 
 ‘fLF ew;wpyj; njz;nza; $o;g; ghz;lq;fs; fliy 
 tLtjhfpa njq;Fkh tUf;if ew;fhak; 
 kbtp yhj nts;Ss;sp nfhs; Gifapiy kJngz; 
 ,lW ghfNyh lfj;jp ePf;fplypr; rhgj;jpak;’ 
- rpj;j kUj;Jthq;f RUf;fk;. 
fLF> vs;nea;> fypahz g+rzpf;fha;> fs;> fliy> Njq;fha; > 
khq;fha;> gyh> fhak;> g+z;L> nfhs;> Gifapiy> ngz;fs; Nrh;f;if> 
ghfy;> mfj;jp ,itfis ,r;rh gj;jpaj;jpy; ePf;f Ntz;Lk;. 
‘Gsp Jth; tpQ;Rk; fwpahy; g+hpf;Fk; thjk;” 
Mjyhy; Gspg;G> Jth;g;G RitAs;s czT tiffis ePf;f Ntz;Lk;. 
‘nra;fO ePh;Nfhile; Njd; kpsF ey;nyz;nza; 
 jq;F ngUq;fhae; jOjhio – vq;nfq;Fk; 
 $l;L rpWKj;Jnea; Nfhjpy; cOe;jpitfs; 
 thl;L kdp yj;ij kjp ” 
- gjhh;j;j Fz rpe;jhkzp. 
Nrh;f;fj;jf;fd :  nrq;fOePh;> Nfh~;lk;> FwpQ;rpj;Njd;> kpsF>  
     vs;nea;> ngUq;fhak;> jOjhioapiy>  
     rpw;whkzf;F nea;> cSe;J. 
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fPy;thjj;jpw;Fhpa Mrdq;fs; 
gj;khrdk;:  
,lJfhiy tyJ njhilapYk;> tyJ fhiy ,lJ njhil kPJk; 
khw;wpg; NghlTk;. fhy; %l;Lfs; ,uz;Lk; jiuiaj; njhl Ntz;Lk.; 
Fjpfhy;fs; ,uz;Lk; tapw;wpd; mbg;ghfj;ijj; njhLk;gbahf 
mikf;fTk;. KJF vYk;ig Neuhf epkph;j;jpf; fk;gPukhf cl;fhu 
Ntz;Lk;. ,uz;L iffisAk; rpd; Kj;jpiuAld; itj;Jf; fz; 
ghh;itia %f;fpd; Edpapy; nrYj;jTk;. 
gyd;fs;; 
 mbtapw;Wg; gFjpf;F ,uj;j Xl;lk; mjpfkhFk;. ed;whfg;grp 
vLf;Fk;. fPy;thj Neha; jPUk;. jtk;> jpahdk;> kd xUikg;ghl;Lf;F 
rpwe;j Mrdk;. cly; mtatq;fs; vy;yhk; tpiwg;ghf ,Uf;fhky;> 
vspjpy; nraYf;F ,zq;Fk;. 
NfhKfhrdk;: 
 Kjypy; fhy;fis ePl;b Neuhf mkh;e;J gpd; tyf;fhiy klf;fp 
,lJ gpl;lj;jpw;F fPo; tuj;jf;fjha; mikj;J mjd; gpd; ,lf;fhiy 
tyJ fhypd; Nkyhf nfhz;L te;J klf;fp tyJ gf;fk; 
,Uf;fj;jf;fjha; itf;f Ntz;Lk;. ,U Koq;fhy; %l;LfSk; 
xd;wd;Nky; xd;W ,Uf;f Ntz;Lk;. KJF vYk;ig Neuhf epkph;;j;jp 
mkh;e;J> tyJ ifia Nkyhf cah;j;jp gpd;GwkhfTk; nfhzh;e;J> ,lJ 
ifia fPohfTk; gpd;GwkhfTk; nfhzh;e;J  ,U iftpuy;fisAk; 
Nfhh;f;f Ntz;Lk;. 
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gyd;fs;: 
 ,jdhy; fPy;thjk; jPUk;. Koq;fhy; nghUj;Jfs;> Koq;if> Njhs; 
nghUj;Jfs;> KJFj;jz;L> ,Lg;g vYk;G ,it gyg;gLk;. EiuaPuYf;f 
ed;F fhw;W nry;Yk;. 
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MODERN ASPECT 
ANATOMY OF KNEE JOINT 
 Knee joint is a hinge joint formed by the condyles of the femur, the 
condyles of the tibia and the posterior surface of the patella.  The anterior part 
of the capsule consists of the tendon of the quadriceps femoris muscle which 
also supports the patella. 
Intracapsular structures include two cruciate ligaments which cross each 
other, extending from the inter condylar notch of the femur to  the inter 
condylar eminence of the tibia.  They help to stabilize the joint. 
Semilunar cartilages or menisci are incomplete discs of white fibro 
cartilage lying on the top of the articular condyles of the tibia.  They are wedge 
shaped, being thicker at their outer edges.  They help to stabilize the joint by 
preventing lateral displacement of the bones. 
Bursae and pads of  fat are numerous.  They prevent friction between a 
bone and a ligament or tendon and between the skin and the patella.  Synovial 
membrane covers the cruciate ligaments and the pads of fat. 
The menisci are not covered with synovial membrane because they are 
weight bearing. The most important strengthening ligaments are the medial and 
lateral collateral ligaments. 
Integrity of the knee joint: 
Lateral motion and rotatory motion of the knee joint in extension is 
controlled by the capsule, collateral ligaments and cruciate ligaments, in 
flexion, by the same structures minus the fibular collateral ligament. 
36 
 
Forward gliding of the tibia on the femur is controlled by the anterior 
cruciate ligament and the quadriceps. 
Backward gliding of the tibia on the femur is controlled by the posterior 
cruciate ligament and the posterior capsule. 
Lateral gliding of the tibia on the femur is controlled by tibia, inter 
condylar spine and the femoral condyles with the aid of all the ligaments. 
Hyper extension is controlled by both collateral ligaments, both cruciate 
ligaments, both menisci, the posterior aspect of the articular capsule, the 
oblique popliteal ligament and the architecture of the femoral condyles. 
Hyperflexion is controlled by both cruciate ligaments, both menisci, the 
femoral attachment of the posterior aspect of the capsule, the femoral 
attachment of both heads of gastrocnemius muscle and the bony, structure of 
the condyles of the femur and the tibia. 
The menisci cushion both hyper extension and hyper flexion.  The tibial 
collateral ligaments are closely related to the medial meniscus but there is no 
strong fibrous tissue attachment between them.  The tibial collateral ligament 
glides forward and backward in extension and flexion. 
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ARTICULAR CARTILAGE 
The ends of the bones in a synovial joint are covered with a layer of 
articular cartilage.  This is an avascular tissue that consists of cartilage cells 
(chondrocytes) embedded in a thick matrix of proteoglycans, water, type II 
collagen and smaller amount of other proteins.  
Although there is no cell division in normal cartilage, chondrocytes are 
metabolically active cells that are responsible for synthesis and turnover of 
cartilage matrix throughout life.  The matrix consists of a meshwork of type II 
collagen fibrils that run through a hydrated gel of proteoglycan molecules, the 
most important of which is aggrecan. 
Aggrecan consists of a core protein, to which several 
glycosaminoglycan (GAG) side chains are attached GAGs consist of long  
chains of disaccharide repeats in which the disaccharide consists of one 
ordinary sugar linked to an amino sugar. 
The most important GAGs, are chondroitin sulphate and keratan 
sulphate.  Cartilage also contains hyaluronan, a long GAG consists of multiple 
glucuronic acid and N-acetyl galactosamine disaccharide repeats.   
Hyaluronan binds several aggrecan molecules by interacting with a 
domain at the N-terminus of the core protein along with a small glycoprotein 
called link protein that acts to stabilise the complex.  Large complexes of 
aggrecan and hyaluronan can form in cartilage with a total molecular weight in 
excess of 100 million. 
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The expansive force of the negatively charged and hydrated aggrecan 
combined with the restrictive force of the collagen meshwork, gives articular 
cartilage excellent shock- absorbing properties. 
With ageing, the amount of chondroitin sulphate decreases whereas that 
of keratin sulphate increases.  The end result is a reduction in water content and 
impairment of cartilage’s shock-absorbing properties.  Age related changes in 
cartilage differ from those found in OA, where there is abnormal chondrocyte 
division, loss of proteoglycan from matrix and an increase in water content. 
Cartilage matrix is constantly being turned over and in health a perfect 
balance is maintained between synthesis and degradation of matrix 
components.  Matrix degradation is thought to be mediated by proteolytic 
enzymes such as aggrecanase and matrix metallo proteinases that degrade the 
core protein of aggrecan and other matrix proteins.  Glycosidases degrade the 
GAG side-chains. 
Group of diseases, termed mucopolysaccharidoses, in which genetic 
mutations in glycosidases occur, resulting in excessive accumulation of GAGs  
in various tissues. 
Pro-inflammatory cytokines such as interleukin (IL-1) and tumour 
necrosis factor (TNF) which are involved in joint inflammation are known to 
upregulate production of aggrecanase, metalloproteinases and other enzymes 
that cause matrix degradation, thereby promoting cartilage damage. 
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This is offset by up regulation of inhibitors of proteinases in cartilage, 
called tissue inhibitors of metalloproteinases (TIMP) which oppose the effects 
of degrading enzymes and protect against matrix degradation. 
Zones of articular cartilage 
1. Superficial layer (tangential zone) 
Makes up 10% of cartilage 
Two Sub Zones 
a. Fibrilar sheet – most superficial layer 
Clear film consisting of a sheet of small fibrils with little 
polysaccharide and no cells. 
b. Cellular layer with flattened chondrocytes: 
Flat chondrocytes and collagen fibers are arranged tangentially to the 
articular surface. 
Thinnest layer, with the highest content of collagen and the lowest 
concentration of  proteoglycans. 
Collagen (type IX) is arranged at right angles to adjacent bundles and 
parallel to the articular surface. 
Subsequently has greatest ability to resist shear stresses and serves as a 
gliding surface for joint. 
May also function to limit passage  of large molecules between synovial 
fluid and cartilage. 
Superficial zone is the first to show changes of osteoarthritis. 
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2.Transitional layer 
This zone involves transition between the shearing forces of superficial 
layer to compression forces in the cartilage layers. 
 composed almost entirely of proteoglycans 
 Spherical chondrycytes 
 Less strongly bound. 
3.Deep radial layer 
 Largest part of the articular cartilage 
 It distributes loads and resists compression 
 Collagen fibres and chondrocytes are perpendicular to subchondral plate 
4.Calcified cartilage layer 
 Contains the tidemark layer 
 Tidemark is basophilic line which stradles the boundary between 
calcified and uncalcified cartilage. 
 Separate hyaline cartilage from subchondral bone. 
 Type X collagen is present mainly in the calcified cartilage layer and in 
hypertrophic zone of the growth plate. 
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OSTEOARTHRITIS 
Synonyms: 
 Degenerative arthritis; degenerative arthrosis; Osteoarthrosis; 
hypertrophic arthritis; post-traumatic arthritis. 
Definition: 
 The term osteoarthritis is currently used to define an idiopathic, slowly 
progressive disease of diarthrodial (synovial) joints occurring late in life and 
characterized pathologically by focal degeneration of articular cartilage, 
subchondral bone thickening (sclerosis), marginal osteochondral outgrowths 
(Osteophytes) and joint deformity. 
 Clinically it is defined by recurring episodes of pain, synovitis with 
effusion, stiffness and progressive limitation of motion and radiologically by 
narrowing of the joint interval, increased density and thickening of the 
subchondral bone, subchondral cysts and marginal bony excrescences. 
Aetiology and Risk factors: 
1. Age ⇒ Radiographic survey 
Women <45 years  - had 2% OA 
   45-64 years  -  30% 
      >65 years  -  68% 
 In Men % some what lower in the older age groups. 
2. Major trauma and repetitive joint use. 
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⇒ Anterior cruciate ligament insufficiency, meniscus damage 
(also meniscectomy), articular cartilage damage lead to 
knee OA. 
⇒ Trimalleolar fracture will certainly develop ankle OA. 
3. Prior vocational or avocational overload. 
  ⇒ Ankle OA common in ballet dancers. 
  ⇒ Elbow OA, OA of shoulder in baseball pitchers. 
  ⇒ Metacarpophalangeal joint OA in prize fighters. 
  ⇒ OA of hands in cotton mill workers. 
  ⇒ Knee OA in footballer. 
4. Obesity – plays a larger role in the etiology of the most serious cases of 
knee OA. 
  For those in the highest quintile for body mass index (BMI) at 
baseline examination, the relative risk for developing knee OA in the 
ensuing 36 years was 1.5 for men and 2.1 for women. 
  For severe knee OA, the risk rose to 1.9 for men and 3.2 for 
women. 
5. Congenital / developmental defects. 
6. Prior inflammatory joint disease. 
7. Hormonal and metabolic effects: 
 Acromegaly notably affects cartilage. 
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 Somatotropin stimulates chondrocytes, resulting in acceleration 
and intensification of metabolic activity.As ages advance, 
somatotropin deficiency becomes pronounced and chondrocytes 
regressive changes and reduced metabolic activity ensue. 
 Diabetes show progressive abnormalities of chondrocytes and 
diabetics are uniquely susceptible to OA. 
8. Chemical injury: 
 Systemically or locally administered chemical agents affect the 
viability and metabolic activity of articular cartilage chondrocytes (eg. 
Steroids). 
9. Repeated Intra Synovial Haemorrhage: 
 In patients with defective clotting factors, repeated haemorrhage 
can lead to damage to articular cartilage and to subchondral bone 
structures.  Iron and pigment in matrix may alter the physical and 
chemical properties of cartilage, or the chondrocytes engulf large 
quantities of iron pigment within their cytoplasm perhaps causing 
lysosomal release of degradative enzymes. 
 It has been shown that the prostaglandin concentration is 
diminished and synthetic activities of the chondrocyte are depressed. 
10. Arthritis can occur as a result of an imbalance between 
mineralocorticoids and gluco corticoids according to Leefore’s a new 
short textbook of psychiatry. 
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PATHOLOGY: 
 The most striking changes in OA are usually seen in load-bearing areas 
of the articular cartilage.  In the early stages the cartilage is thicker than 
normal, but with progression of OA, the joint surface thins, the cartilage 
softens, the integrity of the surface is breached, and vertical clefts develop 
(fibrillation). 
 Remodeling and hypertrophy of bone are also major features of OA.  
Appositional bone growth occurs in the subchondral region, leading to the bony 
“sclerosis” seen radiographically.  The abraded bone under a cartilage ulcer 
may take on the appearance of ivory (eburnation).  Growth of cartilage and 
bone at the joint margins leads to osteophytes (spurs), which alter the contour 
of the joint and may restrict movement.  A patchy chronic synovitis and 
thickening of the joint capsule may further restrict movement.  Periarticular 
muscle wasting is common and may play a major role in symptoms and as 
indicated above, in disability. 
Pathogenesis: 
 The main load on articular cartilage the major target tissue in OA is 
produced by contraction of the muscles that stabilize or move the joint.  
Although cartilage is an excellent shock absorber in terms of its properties, at 
most sites it is only 1 to 2 mm thick, too thin to serve as the sole shock 
absorbing structure in the joint.  Additional protective mechanisms are 
provided by subchondral bone and periarticular muscles. 
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 OA develops in either of two settings: (1) the biomaterial properties of 
the articular cartilage and subchondral bone are normal, but excessive loading 
of the joint causes the tissues to fail, or (2) the applied load is reasonable, but 
the material properties of the cartilage or bone are inferior. 
Pathophysiology of cartilage in OA: 
 Most investigators feel the primary changes in OA begin in the cartilage.  
A change in the arrangement and size of the collagen fibers is apparent.  The 
biochemical data are consistent with the presence of a defect in the collagen 
network of the cartilage, perhaps due to disruption of the “ glue” that binds 
adjacent fibers together in the matrix.  This is among the earliest matrix 
changes observed and appears to be irreversible.  Although “wear” may be a 
factor in the loss of cartilage, strong evidence supports the concept that 
lysosomal enzymes and MMPs account for much of the loss of cartilage matrix 
in OA. 
 The chondrocytes in OA cartilage undergo active cell division and are 
very active metabolically, producing increased quantities of DNA, RNA, 
Collagen, PG, and noncollagenous proteins.  (For this reason, it is inaccurate to 
call OA a “degenerative” Joint disease).  Prior to cartilage loss and PG 
depletion, this marked biosynthetic activity may lead to an increase in PG 
concentration, which may be associated with thickening of the cartilage and a 
stage of homeostasis referred to as “compensated” OA.  These mechanisms 
may maintain the joint in a reasonably functional state for years.  The repair 
tissue, however often does not hold up as in some cases, the rate of PG 
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synthesis falls off and “end-stage” OA develops, with full-thickness loss of 
cartilage. 
Clinical Features: 
 Pain is the usual presenting symptom localized to the involved joint 
aggravated by exertion and relieved by rest.  In the later stage the patient 
may have pain in bed at night.  
Causes of Pain: 
 Since articular cartilage is aneural, the joint pain in OA must arise from 
other structures. 
⇒ due to stretching of nerve endings in the periosteum covering 
osteophytes. 
 ⇒ may arise from micro fractures in subchondral bone. 
⇒ from medullary hypertension caused by distortion of blood flow 
by thickened subchondral trabeculae. 
⇒ Stretching of joint capsule due to joint instability. 
⇒ Muscle spasm. 
⇒ Synovitis. 
 Stiffness of the involved joint on arising in the morning or after a period 
of inactivity (eg. an automobile ride) may be prominent but usually lasts 
less than 20 minutes. 
 On physical examination local tenderness and swelling may be 
intermittent (suggestion an effusion) or continuous (with capsular 
thickening or large osteophytes). 
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 Bony crepitus is characteristic. 
 Synovial effusions usually not large. 
 Palpation may reveal some warmth over the joint. 
 Periarticular muscle atrophy may be due to disease or to reflex 
inhibition of muscle contraction. 
 In the advanced stages of OA, there may be gross deformity, bony 
hypertrophy, subluxation and marked loss of joint motion. 
 
Causes of pain in the joints in patients with OA: 
 Source       Mechanism 
Synovium    ⇒   Inflammation 
Subchondral bone  ⇒   Medullary  
      hypertension,  
      micro fractures. 
Osteophyte    ⇒   Stretching of periosteal  
         nerve endings. 
Ligaments    ⇒   Stretch. 
Capsule    ⇒   Inflammation,  
         distention. 
Muscle    ⇒   Spasm. 
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OA at specific joint sites: 
Erosive OA: 
 Distal and /or proximal interphalangeal joints of the hands are most 
prominently affected.  Erosive OA tends to be more destructive than typical 
nodal OA. 
Generalized OA: 
 Generalized OA is characterized by involvement of three or more joints or 
groups of joints (distal interphalangeal and proximal interphalangeal joints are 
counted as one group each).  Heberden’s and Bouchard’s nodes are prominent.  
Symptoms may be episodic, with “flare-ups” of inflammation marked by soft 
tissue swelling, redness, and warmth. 
Thumb Base: 
 The second most frequent area of involvement of OA is the thumb base.  
Swelling, tenderness, and crepitus on movement of the joint are typical.  
Osteophytes may lead to a “squared” appearance of the thumb base. 
The Hip: 
 Congenital or developmental defects (e.g., acetabular dysplasia, slipped 
capital epiphysis) may be implicated in as many as 80 percent of cases of hip 
OA. 
The Knee: 
 OA of the knee may involve the medial or lateral femorotibial 
compartment and/or the patellofemoral compartment.  OA on the medial 
compartment may result in a varus, (bow-leg) deformity; in the lateral 
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compartment it may produce a valgus (knock-knee) deformity.  A positive 
“shrug” sign (pain when the patella is compressed manually against the femur 
during quadriceps contraction) may be a sign of patellofemoral OA. 
 Chondromalacia patellae, which is also characterized by anterior knee 
pain and a positive shrug sign, is a syndrome of patellofemoral pain, often 
bilateral, in teenagers and young adults.  It is more common in females than in 
males.  It may be caused by a variety of factors (e.g., abnormal quadriceps 
angle, patella alta, trauma).  Although exploration of the knee may reveal 
softening and fibrillation of cartilage on the posterior aspect of the patella, this 
change is usually not progressive; chondromalacia patellae is usually not a 
precursor of OA. 
The Spine: 
 Degenerative disease of the spine can involve the apophyseal joint, 
intervertebral discs, and/or paraspinous ligaments.  Symptoms of spinal OA 
include localized pain and stiffness.  Nerve root compression by an osteophyte 
blocking a neural foramen, prolapse of a degenerated disc, or subluxation of an 
apophyseal joint may cause redicular pain and motor weakness. 
Imaging: 
X-ray.  The four cardinal signs are 
 1. Asymmetric loss of cartilage (narrowing of the joint space). 
 2. Sclerosis of the subchondral bone under the area of cartilage loss 
 3. Cysts close to articular surface and  
 4. Osteophytes at the margins of the joint. 
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Radiological Classification of OA knee (Ahlbach) AP weight bearing and 
lateral Views. 
 Type I  - Joint space narrowing. 
 Type II - Total loss of joint space 
 Type III - < 5 mm tibial erosion but posterior part of the  
plateau intact. 
 Type IV - > 5 mm tibial erosion and erosion of posterior  
plateau. 
 Type V - Subluxation 
Note : Grades IV and V : Total knee replacement is the line of treatment. 
 Radio nuclide scanning shows increased activity during the bone phase in 
the subchondral regions of affected joints.  This is due to increased 
vascularities and new bone formation.  
 Arthroscopy may show cartilage damage long before X-ray changes 
appear. 
Laboratory findings: 
 No laboratory studies are diagnostic for OA, but specific laboratory 
testing may help in identifying one of the underlying causes of secondary OA.  
Because primary OA is not systemic, the erythrocyte sedimentation rate, serum 
chemistry determinations, blood counts, and urine analysis are normal.  
Analysis of synovial fluid reveals mild leukocytosis (<2000 white blood cells 
per microlitre), with a predominance of mononuclear cells.  Synovial fluid 
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analysis is of particular value in excluding other conditions, such as calcium 
pyrophosphate dehydrate (CPPD) deposition disease, gout, or septic arthritis.  
Complications: 
1. Capsular herniation:  OA of the knee is sometimes associated with a 
marked effusion and herniation of the posterior capsule (Baker’s cyst). 
2. Loosebodies:  Cartilage and bone fragments may give rise to loose 
bodies, resulting in episodes of locking. 
3. Rotator cuff dysfunction:  OA of the acromio clavicular joint may cause 
rotator cuff impingement, tendonitis or cuff puncture. 
4. Spinal stenosis:  Long standing hypertrophic OA of the lumbar 
apophyseal joints may rise to acquired spinal stenosis. 
5. Spondylolisthesis:  In patients over 60 years of age, destructive OA of 
the apophyseal joints may result in severe segmental instability and 
spondylolisthesis (degenerative spondylolisthesis) which almost always 
occurs at L4, L5. 
Clinical variants: 
1. Monoarticular and pauciarticular OA: 
 Underlying abnormality acetabular dysplasia, old perthe’s disease or 
slipped epiphysis, a previous fracture or damage to ligments or menisci. 
2. Polyarticular OA: 
 Pain, swelling and stiffness of the finger joints the first carpometocarpal 
and big toe metatarsophalangeal joints or the knees and lumbar facet joints may 
be affected. 
53 
 
 Long standing cases, osteophytes and soft tissue swelling produce a 
characteristic knobbly appearance of the distal inter phalangeal joints 
(Heberden’s node) and less often the proximal interphalangeal joints 
(Bouchard’s nodes). 
3. Endemic OA: 
 OA occasionally occurs as endemic disorder affecting entire 
communities.  It may either due to some environmental factor peculiar to that 
region or to an underlying generalized dysplasia in a genetically isolated 
community. 
4. Neuropathic joint disease (Charcot’s disease): 
 The most destructive arthroplasty is that associated with lack of pain 
sensibility and position sense. 
Differential Diagnosis of OA: 
1. Avascular necrosis: 
 Idiopathic necrosis causes joint pain and local effusion.  Early on the 
diagnosis is made by MRI.  Once bone destruction occurs the X-ray changes 
can be mistaken for those of OA;  The cardinal distinguishing features is that in 
osteonecrosis is the ‘point space’ (articular cartilage) is preserved in face of 
progressive bone collapse and deformity. 
2. Inflammatory Arthropathies: 
 RA, Ankylosing spondylitis and Reiter’s disease may start in one or two 
large joints.  X-rays show a predominantly atrophic or erosive arthritis. 
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3. Polyarthritis of the fingers: 
 Polyarthritis OA may be confused with other disorders which affect the 
finger joints.  ‘Nodal OA’ affects predominantly the distal joints, “Rheumatoid 
Arthritis” the proximal joints and “Psoriatic arthritis” is a purely destructive 
arthropathy and there are no inter phalangeal nodes.  Tophaceous gout may 
cause knobbly fingers, but the knobs are tophi, not osteophytes. 
Management: 
 The management of OA depend upon the joint involved, the stage of the 
disorder, the severity of the symptom, the age of the patient and his or her 
functional needs. 
Early Treatment: 
 There is as yet, no drug that can modify the effects of OA.  Treatments 
is therefore symptomatic.  The principles are 
i. Maintain movements and muscle strength. 
ii. Protect the joint from overload. 
iii. Relieve pain. 
iv. Modify daily activities. 
 
Conservative Treatment: 
1. Rest: The involved joints are rested to reduce compression and shear 
stresses and allow the synovial inflammation to subside. 
2. Range of motion:  The joint is moved through a full range of motion several 
times daily to prevent capsular contraction. 
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3. Load reduction:  protecting the joint from excessive load may slow down 
the rate of cartilage loss.  Measures such as weight reduction for obese 
patients, wearing shock-absorbing shoes, avoiding activities like climbing 
stairs and using a walking stick will pay excellent dividends. 
4. Traction: Traction is used slowing the acute inflammatory phase, 
particularly of a weight bearing joint.  To separate the joint surfaces and to 
stretch the contracted capsule until the inflammation subsides. 
5. Physical therapy:  Moist heat is followed by massage and range of motion 
exercises, both passive and active.  Painful Heberden’s nodes are aided by 
plain hot water soaks or paraffin applications. 
6. Body mechanics:  Good body mechanics is aided by eliminating faulty 
posture, applying shoe supports, and performing graduated exercises of all 
joints. 
7. Orthopaedic appliances:  A removable plaster splint secures rest and 
permits daily physical therapy.  An ordinary elasic bandage applied around 
the affected joint restricts the extremes of motion while permitting a little 
use. 
8. X-ray therapy:  This is supposedly acts by reducing inflammation and 
minimizing scar tissue formation. 
9. Warm, Dry climate. 
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Other Useful Approaches in the management of Osteo Arthritis of 
Hip and Knee joints. 
 Simple changes around the home and daily activities causes dramatic 
improvement in the symptomatology of  osteo arthritis.  The following are 
some of the measures. 
1. Use of higher chair which require less effort to get in and get out should 
be considered. 
2. Patients are advised to climb the stairs leading the good leg taking one 
stair leading with the bad leg,  again taking one stair at a time. 
3. To reduce the force acting across, the injured joint, the patient is advised 
to use a walking stick which acts as a third limb. 
4. Foot wear with hard soles and high heels should be avoided. 
5. Reduction in overweight helps to reduce the load on the joints. 
6. General advice when standing. 
 Keep as upright as possible as this helps to put equal weight on both 
the legs. 
 Avoid sitting on a low or soft chair. 
 To avoid uneven and rough ground or surfaces while walking. 
Exercises in the Management of OA of Hip and Knee. 
Aims: 
 To increase the range of movements. 
 To increase stability and shock absorption . 
 To prevent deformity. 
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 To improve posture. 
 To reduce pain and stiffness. 
Rules: 
 Build up the exercises gradually. 
 Avoid rough ground while exercising. 
 To take warm baths before starting the exercises. 
 To perform the exercises 20 times each twice a day and later four 
times a day. 
Exercises Lying on the Back: 
1. Pelvic Tilt:  Tighten the thigh and buttock muscles, pushing the knees 
flat, hold for a count of five and relax. 
2. Pelvic Lift:  Bend both the knees up, push on the feet and lift, hold for a 
count of five and relax. 
3. Leg Stretch:  Push one leg along the floor as though you are trying to 
make it longer than the other hold for a count of five and then repeat 
with the other leg. 
4. Alternate Leg Raising:  Keeping the knees straight, lift alternate legs 
six inches from the ground. 
Exercises lying on your side, with the Painful Hip up: 
1. Side leg raising:  Keep the top leg straight and lift it up as high as 
possible, hold for a count of five and relax. 
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2. Knee and hip flexion:  Bend the hip and knee of the top leg forwards, 
and hold for a count of five.  Then straighten the leg and stretch back 
wards as far as it will go, hold for a count of five, then relax. 
Exercises in Sitting Posture: 
1. Knee together, feet apart:  Keep the knees together and move the feet 
apart, hold for a count of five then relax. 
2. Feet together, knees apart:  Keep the ankles together and move the 
knees apart, then relax. 
Exercises in Standing Posture: 
1. Standing leg Swing:  Hold into a table or chair with one hand, swing 
one leg forward and backward.  Try to get the backwards swing as wide 
as possible. 
2. Standing side leg swing:  Hold on to a chair with both hands.  Swing 
bad leg out as far as it will go and then in.  The outward swing is the 
hardest part and the leg should be allowed to fall back under muscular 
control. 
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MATERIALs AND METHODS 
 The study Azhal Keel vayu was carried out during the year 2006-2008 at 
Post Graduate Department of Sirappu Maruthvam, Government Siddha 
Medical College and Hospital, Palayamkottai. 
 The cases were selected from the Post-graduate out patient department 
(Sirappu-Maruthuvam) according to the signs and symptoms mentioned in the 
siddha literature. 
Selection of the cases: 
 Certain criteria were followed for the selection of the patients for 
admission. 
Selection Criteria: 
1. Affection of any one of the major joints with or without swelling. 
2. Morning stiffness. 
3. Restricted movements. 
4. Crepitation present in the affected joints. 
 According to the above criteria Sixty Four Cases were treated.  Among 
them Thirty Two Cases were admitted for this study from both sexes of 
various age groups and Thirty Two Cases were treated as out patients.  
Priority for admission was given according to the clinical findings.  The most 
of the signs and symptoms of Azhal Keel vayu correlated with the osteoarthritis 
in modern system of medicine.  Conducting all necessary investigations in 
siddha as well as modern medicine were made to firm the diagnosis. 
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In siddha system the following aspect were taken into consideration. 
 1. Mukkutra Niligal 
 2. Ennvagai thervugal 
3. Udal Kattugalin Nilaigal 
4. Neerkuri, Neikuri 
5. Paruva Kaalangal 
6. Thinaigal 
The following investigations were done in Modern medicine aspect. 
 
HAEMATOLOGICAL INVESTIGATIONS: 
 a) Total WBC count.    e) Blood sugar. 
b) Differential WBC Count.   f) Blood urea. 
c) Erythrocyte Sedimentation Rate. g) Serum cholesterol. 
d) Haemoglobin percentage. 
 
URINE ANALYSIS: 
a) Albumin. 
b) Sugar. 
c) Deposits. 
 
STOOLS EXAMINATIONS: 
a) Ova. 
 b) Cyst. 
 c) Occult blood. 
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SPECIAL INVESTIGATIONS: 
X-ray of the affected joint. 
Selection of the drugs: 
 Selection of the drugs were made after the in-depth study of various 
siddha literature. 
 
The test drugs: 
 Keelvathathuku chooranam (internal) 
 Keelvathathuku thylam (external) 
 
KEELVATHATHUKU CHOORANAM:  2gm twice a day morning and 
night after food  with milk. 
KEELVATHATHUKU THYLAM: 
 This oil was given only for external use on the affected joints. 
 The day before the study started, Vellai Ennai – 15ml was given at early 
morning as a mild purgative to all the patients. 
 The drugs selected for the study were subjected to the Pharmacological 
and Bio-chemical analysis. 
 Pharmacological analysis were done at the Department of 
Pharmacology, and Bio-chemical analysis were done at the Department of 
Biochemistry, Govt. Siddha Medical College, Palayamkottai. 
 All the patients admitted for the study were given uniformly regular 
hospital diet. 
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 During discharge all the patients were advised to attend the out patient 
Department of Sirappu Maruthuvam Post-Graduate Govt. Siddha Medical 
College Hospital, Palayamkottai for the further follow-up. 
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RESULTS AND OBSERAVATIONS 
 
Results were observed with respect to the following criteria: 
1. Sex distribution    11. Prevalent sites 
2. Age distribution    12. Clinical features 
3. Kaalam     13. Mode of onset 
4. Paruva Kaalam    14. Thridosa theory 
5. Thinai      15. Udal Kattugal 
6. Duration of the illness   16. Ennvagai thervugal 
7. Socio-economic status   17. Nei Kuri 
8. Occupational status    18. Yakkai Ilakkanam 
9. Diet references    19. Gunam reference 
10. Precipitating factors    20. Result 
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1.SEX DISTRIBUTION: 
 
 
Among 20 cases, 9 were males and 11 were females. 
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2.AGE DISTRIBUTION: 
 
 
 
 
 
 
 
 
S.No Sex No. of  Cases Percentage 
1. Male 9 45% 
2. Female 11 55% 
S.No Age No. of  Cases Percentage 
1. 0-20 - - 
2. 21-30 - - 
3. 31-40 2 10% 
4. 41-50 2 10% 
5. 51-60 6 30% 
6. 61 and above 10 50% 
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5.THINAI (PLACE): 
 
 
 
 
 
 
 
 
Among the 20 cases, all the cases were belonged to Marutha nilam.   
 
6.DURATION OF THE DISEASE SUFFERINGS: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Among the 20 cases, most of them had the duration of the illness 3 
months and above. 
S.No Thinai No. of Cases Percentage 
1. Kurinji (Hill area) - - 
2. Mullai (Forest area) - - 
3. Marutham (Fertile area) 20 100% 
4. Neithal (Costal area) - - 
5. Paalai (Desert area) - - 
S.No Duration (Months) No. of Cases Percentage 
1. 0-3 7 35% 
2. 3-6 4 20% 
3. 6-12 4 20% 
4. 12-24 1 5% 
5. 24-36 2 10% 
6. 36 and above 2 10% 
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10.ONSET OF DISEASE: 
 
 
 
 
 
 
 
 
 
 According to this study 100% of cases were reported gradual onset of 
disease. 
11.TABLE SHOWING PRECIPITATING FACTORS: 
 
S.No Precipitating Factors No. of Cases Percentage 
1. Exposure to cold 8 40% 
2. Over use of the joint 15 75% 
3. Over Weight 10 50% 
4. Trauma - - 
 
 
 
 
 
  
0
2
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6
8
10
12
14
16
Exposure to cold Over use of the 
joint
Over Weight Trauma
S.No Mode of onset No. of Cases Percentage 
1. Sudden - - 
2. Gradual 20 100% 
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Among the 20 patients 8 (40%) of them showed exposure to cold as a 
precipitating factor and 15 of them (75%) had the history of over use of the 
joint. Ten of them (50%) were over weight. 
 
12.TABLE SHOWING PREVALENCE OF THE JOINT AFFECTION: 
 
 
 
 
 
 
 
 
 
 
 Among the 20 patients in the In-patients ward all the 20 cases (100%) 
had affection of the Knee joints and Ankle joint were in 1 case (5%). 
 
13.TABLE SHOWING CLINICAL FEATURES: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No Affected joint No. of Cases Percentage 
1. Knee (Both) 20 100% 
2. Ankle (Both) 1 5% 
3. Shoulder - 0 
S.No Signs and Symptoms No. of Cases Percentage 
1. Pain, tenderness 20 100% 
2. Swelling 11 55% 
3. Morning stiffness 20 100% 
4. Crepitations 20 100% 
5. Local heat 11 55% 
6. Constipation 14 70% 
7. Loss of appetite 14 70% 
8. Temperature - - 
9. Limited Movements 14 70% 
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 Among the twenty cases all of them had pain, tenderness, morning 
stiffness and crepitation.  70% of the patients had constipation and highly 
painful limited movements. 
14. Radiological Findings: 
 
S No Findings NO of Cases Percentage 
1 Joint Space narrowing 20 100% 
2 Inter condylar notch 
prominence 
9 45% 
3 Osteophytes 16 80% 
4 Subchondral Sclerosis 14 70% 
5 Osteoporosis 18 90% 
6 Deformity 4 20% 
 
Joint Space narrowed in all cases (100%), Osteophytes present in 16 
cases (80%),Osteoporosis present in 18 cases(90%),deformity present in 4 
cases (20%) 
 
14.DISTRIBUTION OF THRIDOSA: 
 
a.Table showing the derangement of vatham: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No Vatham No. of Cases Percentage 
1. Pranan - - 
2. Abanan 14 70% 
3. Viyanan 20 100% 
4. Uthanan - - 
5. Samanan 20 100% 
6. Naagan - - 
7. Koorman 4 20% 
8. Kirukaran - - 
9. Devathathan 10 50% 
10. Dhananjeyan - - 
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BothBoth Viyanan and Samanan were affected in all the twenty cases 
(100%). 
Abanan was affected in 14 cases (70%). 
Devathathan was affected in 10 cases (50%). 
Koorman was affected in 4 cases (20%). 
 
b. Table showing the derangement of Pitham: 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analapitham was affected in 14 cases (70%). 
 Ranjagam was affected in 12 (60%). 
 
c. Table showing the derangement of Kapham: 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No Pitham No. of Cases Percentage 
1. Analapitham 14 70% 
2. Ranjagam 12 60% 
3. Saathagam - - 
4. Prasagam - - 
5. Alosagam - - 
S.No Kapham No. of Cases Percentage 
1. Avalambagam - - 
2. Kiletham 14 70% 
3. Pothagam - - 
4. Tharpagam - - 
5. Santhigam 20 100% 
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In all the 20 cases (100%) Santhigam was affected. Kiletham was 
affected in 14cases (70%). 
15.TABLE SHOWING THE CONDITION OF UDAL KATTUGAL: 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
In all the cases Enbu was affected (100%). 
Senneer was affected in 12 cases (60%). 
Saaram was affected in 14 cases (70%). 
Oon was affected in 5 cases (25%). 
  
S.No Udal Kattugal No. of Cases Percentage 
1. Saaram 14 70% 
2. Senneer 12 60% 
3. Oon 5 25% 
4. Kozhuppu - - 
5. Enbu 20 100% 
6. Moolai - - 
7. Venneer/Suronitham - - 
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16.ENNVAGAI THERVUGAL: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Naadi was affected in all the cases, 12 cases (60%) were Pitha vatha 
Naadi, 4 cases (20%) were Vathapitha naadi, 4 cases (20%) were vatha naadi. 
Naa was affected in 12 cases (60%), Malam was affected in 14 cases (70%).  
 
17.NEIKURI: 
 
Among the 20 cases, the Neikuri result were observed as follows: 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No Ennvagai thervugal No. of Cases Percentage 
1. Naadi 20 100% 
2. Sparisam 11 55% 
3. Naa 12 60% 
4. Niram - - 
5. Mozhi - - 
6. Vizhi 4 20% 
7. Malam 14 70% 
8. Moothiram - - 
S.No Neikuri No. of Cases Percentage
1. Spreading like a snake 4 20% 
2. Spreading like a ring 6 30% 
3. Spreading like a pearl - - 
4. Combined of ring and snake 10 50% 
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18.YAKKAI ILAKKANAM (PHYSICAL CONSTITUTION): 
 
 
 
 
 
 
 
 
 
 
 
 
Among the 20 cases, the majority were of Thontha udal. 
 
 
19.GUNAM (QUALITY AND CHARACTERS): 
 
 
 
 
 
 
 
 
 
 
 Most of the cases had Rajo gunam. 
20.Results: 
 
 
 
 
 
 
 
 Among the twenty cases taken for this study who were admitted in the 
In-patient ward, 12 cases (60%) showed improvement.  8 cases (40%) showed 
partial improvement.  The results were based on the clinical improvements, the 
author had tried not only medicines but also recommended yoga therapy. 
S.No Yakkai Ilakkanam No. of Cases Percentage 
1. Vatha udal 4 20% 
2. Pitha udal 2 10% 
3. Kapha udal 2 10% 
4. Thontha udal 12 60% 
S.No Gunam No. of Cases Percentage 
1. Sathuva Gunam - - 
2. Rajo Gunam 16 80% 
3. Thamo Gunam 4 20% 
S.No No. of Cases Results Percentage 
1. 12 Improved 60% 
2. 8 Partially Improved 40% 
 40%
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DISCUSSION 
 
 Azhal Keel vayu is one of the major bony joint problems i.e. really the 
movable joints affected which makes the elder people most troublesome 
especially.  The disease Azhal Keel vayu as explained in Siddha system of 
medicine has got close resemblance with that of osteoarthritis of modern 
system of medicines in conservation as well as clinical importance. 
 The drugs used to treat this disease were Keelvathathuku chooranam 
internally and Keelvathathuku thylam externally.  This study is a trial to 
throw light the role of the drugs in all aspects in the management of the disease. 
 Thirty two cases of Azhal Keel vayu were admitted in the In-patient 
ward who were diagonosed clinically on the basis of signs and symptoms 
described in the text “siddha maruthuvam”.  The clinical diagnosis was made 
confirmed by means of other siddha aspects of examinations.  Out of thirty two 
cases, twenty were selected for this study. 
Sex Distribution: 
 Among the twenty cases, 9 (45%) were male and 11(55%) were female 
patients.  It shows men and woman are more or less equally affected. 
Age distribution: 
 According to this study most of the patients were above the age of 50.  
Only 4 (20%) were reported in between the age group of 30 to 50. 
Prevalence of affecting the joints: 
 In Azhal Keelvayu the hallmark of involvements are articular joints.  
The involvement of the ailment was mostly found out in the knee joints. 
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 Both the Ankle joint were affected in 5% cases. 
Duration of the illness: 
 According to this study the duration of the illness varied from 3 months 
to 2 years.  Naturally, this disease is a chronic one unless any history of trauma.  
Because, this disease as already told, a slow, progressive disorder most 
probably encouraging degenerative condition. 
Socio-economic status: 
 Among the 20 cases selected for this study, 15 cases (75%) were poor 
class and only 5 cases (25%) were middle class family. 
Occupation status: 
 According to this study, the 6 cases (30%) were agriculturists. 
Precipitating Factors: 
 According to this study exposure to cold, exessive use of the knee joint 
and obesity were played a major role. 
Prevalence of the joint affection: 
 According to this study all the 20 cases (100%) had affection of the knee 
joints.  One case had affection of the ankle joint. 
Clinical manifestation: 
 Among the twenty cases, all of them had pain, tenderness, morning 
stiffness, crepitation etc, most of them were reported with mild swelling, 
slightly restricted movements, loss of appetite and habitual constipation. 
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Paruva Kaalam: 
 In the disease of keel vayu, being a vadha disease according to many 
siddha literature, vadham gets vitiated in munipani kaalam.  Here the higher 
incidence of the disease was in Pinpani and Koothir Kaalams. 
Thinai: 
 In this study it was observed that all of the cases were from Marutha 
Nilam. 
Disturbance in Vatham: 
 In the twenty cases, in all of them (100%) Viyanan and Samanan were 
affected.  Abanan was affected in 14 (70%) cases.  Devathathan was affected in 
10 cases (50%).  Koorman was affected in 4 cases (20%).   
Disturbance in Pitham: 
 According to this study Analapitham and Ranjagapitham were affected 
in 14 (70%) and 12 (60%) cases respectively. 
Disturbance in Kapham: 
 According to this study santhiga kapham was affected in all the cases 
(100%).  Kiletham was affected in 10 (50%) cases. 
Udal Kattugal: 
 Among the Seven udal Kattugal, Saaram and Senneer were affected in 
14 (60%) and 12 (60%) cases respectively.  Oon was affected in 5 cases (25%).  
In all the cases (100%) Enbu was affected. 
Gunam: 
 According to this study, 16 cases (80%) had Rajo gunam. 
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Ennvagai thervugal: 
 According to this study, in Ennvagai thervugal, Naadi was affected in all 
the cases (100%), Naa was affected in 12 cases (60%).  Sparism was affected in 
11 cases (55%).  Vizhi was affected in 4 cases (20%). 
Neikuri: 
 Among the 20 cases, 50% of the cases showed thondha neer. 
Laboratory Investigation: 
 The available laboratory investigations were done in the Govt. Siddha 
Medical College, Palayamkottai.  Routine examination of blood, urine and 
stools were done during the admission and discharge.  Examination of urine 
and stools showed no abnormalities.  All the shown values have been recorded 
in the Investigation table.  In all the cases X-rays showed osteophytic changes 
and marginal erosion. 
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SUMMARY 
 
1. Sixty four cases with Azhal Keelvayu, diagnosed clinically.  Out of 
them thirty two cases were admitted in the in-patient PG Sirappu 
Maruthuvam Ward, Govt. Siddha Medical College Hospital, 
Palayamkottai were observed for clinical diagnosis, lab diagnosis and 
treatment by the trial medicines.  Out of them twenty cases were 
selected for study. Thirty two cases were treated as out patients. 
2. Clinical diagnosis of Azhal Keel vayu was done on the basis of clinical 
features described in the siddha text books. 
3. Laboratory diagnosis of Azhal Keelvayu was done by modern methods 
of examination in the Govt. Siddha Medical College Hospital, 
Palayamkottai. 
4. The various siddha aspects of examination of the disease were carried 
out and recorded in a proforma. 
5. The trial medicines chosen for both internal and external treatment and 
the management of Azhal Keelavayu  
• Keelvathathuku chooranam as per the severity of the complaints, the 
dosage were given 2 gm two times a day with  milk for twenty days 
and above. 
• Keelvathathuku thylam (Externally). 
6. Before starting the treatment, careful detailed history was carried out 
and recorded from the twenty selected patients. 
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7. During the period of treatment, all the patients were put under strict 
pathiyam-a specific dietary regimen. 
8. The observation made during the clinical study shows that the main drug 
Keelvathathuku chooranam (Internally) is clinically effective . It has 
moderate analgesic action and significant anti inflammatory action.  
9. The action of Keelvathathuku thylam (Externally) over the affected 
joint was also clinically effective.It has Significant anti inflammatory 
action. 
10. A periodical laboratory investigation were made for all the case for 
blood, urine and motion test etc., along with radiological reports. 
11. Since Azhal Keel vayu is a chronic disease, it required minimum 
treatment for twenty days, treated both internally and externally to 
minimize the severe pain, tenderness and Swelling, but also slight 
disappearance of the crepitation. 
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CONCLUSION 
 
 
All the twenty patients Selected for this Study were treated with 
Keelvathathuku chooranam (Internal 2gm bd with milk) and 
Keelvathathuku thylam (Externally). 
 Clinical results show improvement in large number of the cases that is 
60%.  During the meantime of treatment, under admission all the Azhal Keel 
vayu patients were instructed and guided to follow the following asanas. 
  a) Komugaasana - The Cow head Posture 
  b) Padmasana  - The Lotus Posture 
 It was sure that no one had any remission up to 6 months. 
 If any further recurrence or no satisfied improvement, the individuals 
were instructed to follow up treatment both internally and externally.  It is very 
pleasurable to say here, the author highlights the trial medicines are found 
effective just relieved from pain and tenderness, severe morning stiffness, 
severe crepitation, arresting of marked swelling and so on. 
It was noted that the internal drug Keelvathathuku Chooranam was 
free from adverse side effects, i.e. no cases were reported either nausea or 
vomiting and the external application Keelvathathuku thylam was not irritant, 
i.e. no cases were reported itching or inflammation or eruption wherever 
massaged. 
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fPy;thjj;Jf;F #uzk; : 
  MfhrfUld; fpoq;F #uzk; 
  gwq;fpg;gl;il #uzk;. 
Mjhuk; : Fzg;ghlk; %ypif tFg;G gf;fk; : 652>61 
Mfhrf;fUld; fpoq;F: 
Botanical Name : Corallocarpus eipgaeus Benth. ex. Hook. 
NtW ngah;fs; : MfhrnfUld;> MfhafUld;> fUld;> nfhy;yd;  
 Nfhit> Nga;r;rPe;jpy;. 
English Name : Bryoms.  
Family  : Cucurbitaceae 
tshpay;G  : VWnfhb. 
gad;gLk; cWg;G : fpoq;F. 
Rit   : ifg;G 
jd;ik  : ntg;gk; 
gphpT   : fhh;g;G. 
nra;if  : clw;Nww;wp> cukhf;fp. 
Fzk;  :  
‘Jl;ltplk; ghz;L ntg;G #iy thjq; fpue;jp  
Fl;lk; mhpg;gf;fp Nfhz;Fly;Neha; - nfl;lfz;l    
khiyNghk; nfhy;yd; Nfhitf; fpoq;fhy; Kj;Njhl  
NtiyNghk; ghhpy; tpsk;G.” 
- mfj;jpah; Fzthflk;. 
fpoq;fpd; Nkw;Nwhiy ePf;fp epoypYyh;j;jp> Ez;zpa nghb  nra;J 
miu Kjy; xU tuhfndil vLj;J fhiy khiy ,UNtis cz;L 
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Gsp> cg;G ePf;fp gj;jpaq; fhf;f ghk;Gf;fb eQ;R> fPy;gpbg;G> NkfNeha;fs; 
kw;Wk; Nkw;fz;l Neha;fs; jPUk;. 
Chemical constituents  : Bryonin 
gwq;fpg;gl;il  
Botanical Name : Smilax china. 
Family  : Liliaceae 
English Name : China root. 
NtW ngah;fs; : kJ];kpfk;> kJ];kPfp> rPdg;gl;il>  
 gwq;fpr;rf;if. 
gad;gLk; cWg;G : fpoq;F 
Rit   : ,dpg;G 
jd;ik  : jl;gk; 
gphpT   : ,dpg;G 
nra;if  : clw;Nww;wp> Nkfg;gpzptpyf;fp> fhkk; ngUf;fp> 
    J}a;ikahf;fp. 
Fzk;  : 
   ‘jhfk; gythje; jhJel;lk; Gz;gpsit 
   Njfq; fbfpue;jp tPo;%ye; - NjfKld; 
   Fl;il gfe;jNkw; nfhs;tkdk; Nghk;gwq;fpg; 
   gl;ilapid Ar;rhpj;Jg; ghh;.” 
- Njiuah; Fzthflk; 
,jdhy; ePh; Ntl;if> gw;gy tspNeha;> Gz;> FiwNeha;>  Iak>; 
the;jp jPUk;. 
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Chemical Constituents : 
! Starch, Glucosides, Ergosterol, Sarsasapogenin equivalent to cortisone  
( steroid ) 
!
toq;Fk; Kiw : 
 ,ij nghbnra;NjDk; FbePhpl;NlDk; nfhLj;Jtu Nkw;fz;l 
Neha;fs; jPUk;. 
fPy;thjj;Jf;F ijyk; : 
fz;lq;fj;jphp FbePh;  - 1 ypl;lh; 
ey;nyz;nza;   - 1 ypl;lh; 
gspq;Fr; rhk;gpuhzp  - 100 fpuhk; 
gr;irfw;G+uk;.   - 10 fpuhk; 
Mjhuk; : %ypif kh;kk; ehd;fhk; ghfk; gf;fk; : 218 
nra;Kiw:  
 fz;lq;fj;jhp  FbePUld; rkmsT ey;nyz;nza; Nrh;j;J 
mLg;Ngw;wp vhpj;J kzw;gjj;jpy; ,wf;Fk; jUthapy; gspq;Fr;  
rhk;gpuhzpAk;> gr;ir fw;G+uKk; ,l;L cUfpaJk; tbfl;b vLj;Jf; 
nfhs;s Ntz;Lk;. 
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fz;lq;fj;jphp  : 
Botanical Name  : Solanum surattense Burm. f. 
English Name  : Wild eggs plant; Bitter-sweet woody Nightshade,  
     Yellow-berried nightshade. 
Family   : Solanaceae. 
tshpay;G   : nrb 
gad;gLk; cWg;Gfs; : ,iy> G+> fha;> gok;> tpij> Nth;. 
Rit    : fhh;g;G 
jd;ik    : ntg;gk; 
gphpT    : fhh;g;G 
nra;if   : Nfhioafw;wp> rpWePh;g;ngUf;fp>  
 mfl;Ltha;tfw;wp. 
,iy    : 
 ,jd; ,iyr;rhw;wpy; my;yJ ,jd; FbePhpy; vz;nza; fye;J 
fha;r;rpg; G+rptu jiytyp> 
fPy;thjk;> mf;Fs; ehw;wk; Kjypait ePq;Fk;. 
gr;irf; fw;G+uk; : [ BORNEO CAMPHOR ] 
NtWngah;fs; : ,kthYfk;> fjypAg;G> nfspj;jpg; gr;ir> rrp>  
re;jpud;> ghh;kfd;rhhp> NrhkDg;G> rPjsk;>   
rPjfw;G+uk;> gr;irg; G+uk;> gypif> G+uk;> kjp>  
kUthsp> tpe;jk;> tpuypg; gr;ir> ,utpf;fQ;rp>  
gr;irf; fdrhuk;. 
Rit   : ifg;G> cg;G 
tPhpak;  : rPjtPhpak;> tpWtpWg;G cilaJ  
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nra;if  : Fsph;r;rpAz;lhf;fp> cly; cuKz;lhf;fp>  
 Nfhioafw;wp. 
Fzk;  : 
   ‘ml;lFd;kQ; #iy aZfhJ thjnkhL 
    Jl;lNk fgg;gpzpAe; Njhw;whNj – kl;lyUq; 
    $e;jYil khNj nfhbafgk; NghFQ; 
    rhh;gr;irf; fh;g;G+uj; jhy;”. 
 gr;irfw;G+uj;jhy; vz;tpj Fd;kq;fs;> fPy;fspy; Fj;jy;>  
thjNeha;> rPo;g;gpuNkfk;> rpNy~;k Nfhgk; ePq;Fk;. 
gspq;Fr; rhk;gpuhzp: 
Botanical name :- STYRAX BENZOIN 
NtW ngah;fs;  : ngz; FikQ;rhd;> J}gk;> kyhf;fhr; rhk;gpuhzp 
English Name :  Benzoin, Indian Olibanum tree. 
Family  :  Styraceae. 
gad;gLk; cWg;G  : gprpd; 
Rit   : fhh;g;G 
jd;ik   :  ntg;gk; 
gphpT    : fhh;g;G 
nra;if : ntg;gKz;lhf;fp> Nfhioafw;wp> rpWePh;g;ngUf;fp 
gad; : ,jdhy; tspNeha;fs;> IaNeha;fs;> ePh;g;gPdpRk; jPUk</!
Chemical Constituents: Benzoic acid 
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fz<oz{<o{b<!)!wt<!ofb<!*!
English Name :  Gingelly oil 
Botanical Name :  Sesamum indicum 
Family  :  Pedaliaceae 
Rit   : ,dpg;G 
jd;ik  : ntg;gk; 
gphpT   : ,dpg;G 
Fzk;  : 
   ‘nrg;ghpa thjgpj;jj; jPikafYk; ” 
gad;fs;  : 
 cly; td;ik jUk;. thjgpj;j Neha;fs; jPUk;. 
!
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GOVT SIDDHA MEDICAL COLLEGE, 
PALAYAMKOTTAI 
BIO-CHEMICAL ANALYSIS 
Preparation of the extract: 
 5gms of choornam was weighed, accurately and placed in a 250ml clean 
beaker.  Then 50ml distilled water is added and dissolved well.  Then it is 
boiled well for about 10 minutes.  It was cooled and filtered in a 100ml 
volumentric flask and then it is made up to 100 ml with distilled water.  This 
fluid is taken for analysis. 
Qualitative analysis: 
S.No Experiment  Observation  Inference 
1. TEST FOR CALCIUM 
2ml of the above prepared 
extract is taken in a clean test 
tube.  Add 2 ml of 4% 
ammonium oxalate solution is 
added to it 
A white precepetate 
is formed  
Indicates the 
presence trace 
amount of calcium 
is present. 
2. TEST FOR SULPHATE 
2ml of the extract is added to 5% 
barium chloride solution 
No white 
precepetate is 
formed  
Absence of 
Sulphate 
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3. TEST FOR CHLORIDE 
The extract is treated with silver 
nitrate solution 
No white 
precepetate is 
formed  
Absence of 
Sulphate 
4. TEST FOR CARBONATE  
The substance is treated with 
concentrated HCL. 
No brisk effer 
vessence is formed  
Absence of 
Carbonate 
5.  TEST FOR STARCH 
The extract is added with weak 
iodine solution 
Blue colour is 
formed 
Indicates the 
presence of starch. 
6. TEST FOR IRON 
FERRIC: The extract is treated 
with glacial acetic acid and 
potassium ferro cyanide. 
No Blue color is 
formed 
Absence of ferric 
Iron 
7. TEST OF IRON FERROUS: 
The extract is treated with 
concentrated nitric acid and 
ammonium thio cyanate 
No blood red colour 
is formed  
Absence of ferrous 
iron. 
8. TEST FOR PHOSPHATE 
The extract is treated with 
ammonium Molybdate and 
concentrated nitric acid. 
No yellow 
precepetate is 
formed  
Absence of 
phosphate 
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9. TEST FOR ALBUMIN 
The extract is treated with 
Esbach’s reagent. 
No yellow 
precepetate is 
formed 
Absence of 
Albumin. 
10. TEST FOR TANNIC ACID. 
The extract is treated with Ferric 
Chloride reagent.  
No blue back 
precepetate is 
formed. 
Absence of Tanmic 
acid. 
11. TEST FOR UNSATURATION 
Potassium permanganate 
solution is added to the extract. 
It gets decolourised. Indicates the 
presence of 
unsaturated 
compound. 
12. TEST FOR THE REDUCING 
SUGAR. 
5ml of Benedict’s qualitative 
solution is taken in a test tube 
and allowed to boil for 2 mts and 
added 8-10 drops of the extract 
and again boil it for 2 mts. 
Colour change 
occurs. 
Indicates the 
presence of 
Reducing Sugar. 
 
13. TEST FOR AMINO ACID. 
One or two drops of the extract is 
placed on a filter paper and dried 
it well, after drying 1% 
Ninhydrin is sprayed over the 
same and dried it well. 
Violet colour is 
formed. 
Indicates the 
presence of Amino 
acid. 
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ANALGESIC STUDY OF KEELVATHATHUKU 
CHOORANAM 
Aim    
To study the effects of analgesic action on albino rats by tail flick 
method. 
Instruments 
 
 Analgesiometer using heated nicrome wire as the source of stimulus. 
Procedure: 
 Two groups of rats on either sex were selected, each group having three 
rats and each rat was put inside a rat holder with the tail projecting out fully.  
The tip of the tail was kept over the nicrome wire of the analgesiometer.  To 
heat the nicrome wire by switching it on and at the same time starting a 
stopwatch.  The time takes for the rat to flick the tail was noted.  This was kept 
as the control volume. 
 Paracetamol was administered at a dose of 20mg/100gm of body weight 
orally to the test group.  The reaction time was noted after the administration 
half an hour and one hour and the average is calculated. 
 When a rat fails to flick the tail, it should be continued beyond eight 
seconds to avoid injury. 
The result of drug treated group and control group were tabulated and 
compared. 
 
95 
 
Group 
Dose/100mg 
Body weight 
Initial 
reading 
(in Sec ) 
After ½ 
hour 
(in Sec) 
After 1 
hour 
(in Sec) 
 
Control Water 2ml 2 3 2 
Standard Paracetamol- 
20mg 
 
 
2 
 
6 
 
7 
Test drug 200mg 2 3 4 
 
Inference: 
 The test drug seems to have moderate analgesic action 
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CHRONIC ANTI-INFLAMMATORY STUDY BY 
COTTON-PELLETS GRANULOMA METHOD 
Drug 
 Keelvathathuku  Chooranam 
Aim 
 To study the chronic anti-inflammatory activity of the drug in albino rats 
by cotton pellets implantation (granuloma) method. 
Procedure: 
 Cotton pellets each weighing long was prepared and sterilized in an 
autoclave for about one hour under 15 lbs atmosphere pressure.  Nine Albino 
rats weighing between 100-200gm were selected and were divided into 3 
groups.  Each rat was anaesthetized with ether and cotton pellets were 
implanted subcutaneously in the groin, two in each side. 
 From the day of implantation, one group of animals received 
keelvathathuku chooranam at a dose of 200mg/100gm of body weight.  
 On the eighth day the rats were sacrificed and the pellets were removed 
weighed.  Then they were put in an incubator at 60ºC-80ºC and then weighed. 
The concordant weight was noted for all groups and compared. 
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The effect of Keelvathathuku chooranam in chronic anti 
inflammatory study. 
 
Group 
Dose given 
orally 
Concordant 
weight in 
mgs 
Percentage 
inflammation
Percentage 
inhibition 
Control Water 2ml 250 100 - 
Standard 
Ibuprofen 
20mg/100gm 
body weight 
 
56 
 
22.4 
 
77.6 
Test drug 
200mg/100gm
body weight 
147 59 41 
 
Inference : 
 The drug show moderate chronic – anti inflammatory action. 
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ACUTE ANTI-INFLAMMATORY ACTIVITY IN RATS 
BY HIND-PAW METHOD 
To demonstrate the acute anti-inflammatory activity of  
KEELVATHATHUKU CHOORANAM in albino rats by Hind-paw method. 
Procedure: 
 Nine Albino rats weighing 100-150gm were taken and divided into three 
groups and each group consisting three rats. 
 First group was kept as control land received water.  Second group 
received lbuprofen at a dose of 20mg/100gm-body weight.  Third group 
animals received keelvathathuku chooranam suspension at a dose of 
200mg/100gm-body weight. 
 Before administration of drugs, the Hind-paw volume of all the rats 
were measured.  This was done by dipping the Hind-paw upto the ribio-tarsal 
junction in mercury plethysmograph.  Soon after the measurement at the drugs 
were administered.  One hour after the administration of drugs a sub-cutaneous 
injection of 0.1ml of 1%/W/V of carrageenin in water was made into planter 
surface of both the Hind-paw of each rat. 
Three hours after carrageenin injection, the Hind-paw volume was 
measured once again.  Difference between the initial and final value were noted 
and compared. 
This method is more suitable method for studying anti-inflammatory 
activity in acute inflammation. 
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The effect of Keelvathathuku chooranam in acute anti-inflammatory 
activities. 
 
Group 
Dose volume 
orally 
Initial 
reading 
Final 
reading 
Mean 
difference 
Percentage 
Inflammation 
Percentage 
Inhibition 
Control Water 2 ml 0.55 1.4 0.85 100 - 
Standard 
Ibuprofen 
20mg/100gm 
0.55 0.85 0.3 35.3 64.7 
Test 
drug 
200mg/100gm 0.66 0.93 0.27 39.7 60.3 
 
Result: 
 The drug keelvathathuku chooranam has significant acute – anti 
inflammatory action. 
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ACUTE ANTI – INFLAMMATION SSTUDY ON 
KEELVATHATHUKU (EXTERNAL USE) BY HIND-PAW 
METHOD I ALBINO RATS 
Aim: 
 To study the acute anti-inflammatory activity of the test drug 
KEELVATHATHUKU THYLAM. 
Preparation of the test drug: 
 The keelvathathuku thylam was prepared as per the preparation in 
Mooligai Marmam Part IV. 
Procedure: 
 Six healthy albino rats weighing 100-150gm were taken and divided into 
three groups, each consisting of 2 rats. 
 First group was kept as control by giving distilled water of 2ml/100gm 
of body weight.  The second group was kept as test group.  The third group was 
given the standard drug. 
 Before application of the test drug the Hind-paw volume of all the rats 
were measured.  This was done by dipping the Hind-paw (up to the tibio-
femoral junction) into a mercury plethysmograph.  While dipping the Hind-
paw, by pulling the syringe piston, the level of mercury in the centre small tube 
was made to coincide with red marking and reading was noted from the 
plethysmograph. 
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 One hour later, a sub-cutaneous injection of 0.1ml of 1%(w/r) 
Carrageenin water made into  plantar surface of both Hind-paw of each rat.  To 
the second (last) group keelvathathuku thylam was topically applied for three 
times over the inflammed surface in a thin layer for every 15mts for an hour.  
To the other group no drug was applied over the inflammed surface. 
 Three hour after injection the Hind-paw volume was measured once 
gain.  The difference between the initial and final volume would show the 
amount of inflammation.  Taking the volume in the control group as 100% of 
inflammation, anti-inflammatory effect of the test group is calculated. 
EFFECT OF KEELVATHATHUKU THYLAM: 
Group Drugs 
Dose 
100gm 
of 
body 
weight 
Initial 
value 
Final 
value 
Difference
Percentage 
Inflammation 
Percentage
Inhibition 
Control Water 2ml 0.55 1.4 0.85 100 
- 
 
Standard Ibuprofen 20ml 0.55 0.85 0.3 35.3 64.7 
Test 
drug 
Keelvathathuku 
thylam. 
Ext 1 1.2 0.2 22.2 77.8 
 
Inference: 
 The test drug has significant Anti-Inflammatory action  externally. 
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PROFORMA OF CASE SHEET 
GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI. TRIRUNELVELI – 627 002 
Branch – III Sirappu Maruthuvam 
Dissertation done by: 
I.P. No  :  Occupation   : 
Bed No  :  Income   : 
Ward   :  Nationality   : 
Name   :  Religion   : 
Age   :  Date of Admission  : 
     Date of Discharge  : 
Sex   :  Diagnosis   : 
     Result   : 
     Medical Officer  : 
Permanent Address : 
 
Complaints and duration : 
 
History of present illness : 
 
History of Previous illness : 
 
Personal history including habits: 
 
Family History  : 
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GENERAL CONDITIONS ON EXAMINATION 
 
1. Consciousness   : 
 
2. General appearance  : 
 
3. Stature    : 
 
4. Nourishment   : 
 
5.Skin Changes   : 
 
6. Face    : 
 
7. Pallor    : 
 
8. Jaundice    : 
 
9. Cyanosis    : 
 
10. Clubbing   : 
 
11. Lymphadenopathy  : 
 
12. Abdominal Distension : 
 
13. Jugular Venous Pulsation : 
 
14. Engorged Veins  : 
104 
 
15. Koilonychia   : 
 
16. Pedal oedema   : 
 
17. Generalised Oedema  : 
 
18. Temperature   : 
 
19. Pulse    : 
 
  Rate   : 
  Rhythm  : 
  Volume  : 
  Character  : 
  peripheral pulses : 
  Pulses paradoxus : 
     
20. Respiratory Rate  : /min 
21. Heart Rate   : 
22. Blood pressure   : 
 Right Left 
Upper limb   
 
23. Miscellaneous   : 
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rpj;j Kiw NjHT 
 
1.  epyk; 
 FwpQ;rp 
 Ky;iy 
 kUjk; 
 nea;jy; 
 ghiy 
2. gUt fhyk; 
 fhH fhyk;   (Mtzp - Gul;lhrp) 
 $jpH fhyk;  (Ig;grp - fhHj;jpif) 
 Kd;gdp   ( khHfop - ij 
 gpd;gdp   ( khrp- gq;Fdp) 
 ,sNtdpy;  ( rpj;jpiu - itfhrp) 
 KJNtdpy;  ( Mdp - Mb) 
 
3. ahf;if (cly;) 
 thjk; 
 gpj;jk; 
 fgk; 
 fyg;G 
4. Fzk; 
 rj;Jtk; 
 ,uhrjk; 
 jhkrk; 
5. nghwp Gyd;fs; 
 nka; - CW 
 tha; - Rit 
 fz; - xsp 
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 %f;F - ehw;wk; 
 nrtp - xyp  
6. fd;nke;jphpak; 
 if - jhdk; 
 fhy; - fkdk; 
 tha; - trdk; 
 tUtha; - tprHf;fk; 
 fUtha; - Mde;jk; 
7. cl;fhak; 
 Njhs; nghUj;J 
 Gak; 
 Koq;if nghUj;J 
 rak; 
 iff;FsR 
 fugk; 
 mq;Fyp 
 mq;Frk; 
8. mjf;fhak; 
 ,Lg;G nghUj;J 
 njhil 
 Koq;fhy; nghUj;J 
 Kd;fhy; 
 Fjpq;fhy; 
 fugk; 
 mq;Fyp 
 tk;rp 
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9. Kk;kyk; 
 kyk;    - 
 %j;jpuk;   - 
 tpaHit   - 
10. gpw cWg;Gfspd; epiy 
 ,Ujak;   - 
 Gg;Grk;   - 
 ,iug;ig   - 
 fy;yPuy;   - 
 kz;zPuy;   - 
 rpWFly;   - 
 ngUq;Fly;  - 
 rpWePufk;   - 
 %is   - 
 fUg;ig   - 
11. capH jhJf;fs; 
(m) thjk;   - 
 gpuhzd;   - 
 mghdd;   - 
 tpahdd;   - 
 cjhdd;   - 
 rkhdd;   - 
 ehfd;   - 
 $Hkd;   - 
 fpUfud;   - 
 Njtjj;jd;   -  
 jdQ;nrad;  - 
(M) gpj;jk; 
 mdw; gpj;jk;  - 
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 ,uQ;rf gpj;jk;  - 
 rhjf gpj;jk;  - 
 MNyhrf gpj;jk;  - 
 gpuhrf gpj;jk;  - 
(,) fgk; 
 mtyk;gfk;   - 
 fpNyjfk;   - 
 Nghjfk;   - 
 jw;gfk;   - 
 re;jpfk;   - 
12. cly; jhJf;fs; 
 rhuk;    - 
 nre;ePH   - 
 Cz;    - 
 nfhOg;G   - 
 vd;G    - 
 %is   - 
 Rf;fpyk;/RNuhzpjk; - 
13. vz; tifj;NjHTfs;  
 ehb    - 
 ];ghprk;   - 
 eh    - 
 epwk;    - 
 nkhop   - 
 tpop    - 
kyk; 
 epwk;    - 
 vil    - 
 ,Wfy;   - 
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 ,sfy;   - 
rpWePH 
1 ePHf;Fwp 
 epwk;    - 
 kzk;   - 
 vil    - 
 Eiu    - 
 vQ;ry;   - 
2. nea;f;Fwp 
LABORATORY INVESTIGATION 
1. BLOOD: 
 TC : cells/ cu. mm 
 DC :   P % L % E % M % 
 ESR : 
   ½ hour : mm 
    I hour : mm 
 
 Hb    : 
 Blood Sugar  : 
 Blood Urea  : 
 Serum Cholesterol : 
 Uric Acid  : 
 VDRL  : 
2. URINE 
 Albumin  : 
 Sugar   : 
 Deposits  : 
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3. Motion 
 Ova   : 
 Cyst   : 
4. IMMUNOLOGICAL : 
 RA Factor  : 
5.RADIOGRAPHIC FINDINGS : 
6. SEROLOGICAL TEST FOR SYPHILIS : 
7. SYNOVIAL FLUID ANALYSIS : 
8. ARTHROGRAPHY : 
1. LOCOMOTOR SYSTEM 
INSPECTION 
Overlying Skin: 
 Colour   : 
 Scars and ulcers  : 
 Periarticular swelling : 
Bones: 
 Deformity   : 
 Unusual posture  : 
 Muscle changes  : 
 Symmetrical distribution : 
 joint movements  : 
 Gait    : 
Palpation: 
 Skin Temperature  : 
 Soft Tissues   : 
 Bony Enlargement  : 
 Crepitus   : 
 Sub-cutaneous nodules : 
 Rheumatoid vasculitic lesion : 
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 Lymphadenopthy  : 
 pitting Iedema  : 
Range of Movements  : 
Examination of individual joints: 
 Cervical Spine  : 
 Thoracic Spine  : 
 Lumbar Spine  : 
 Sacro-illac Joint  : 
 Shoulder Joint  : 
 Elbow Joint   : 
 Wrist Joint   : 
 Metacarpophalangeal joint : 
 Interphalangeal Joint : 
 Hip Joint   : 
 Knee joint   : 
 Metatarso phalangeal Joint: 
 
Examination of individual joints (Affected Joints) 
Measurement (in inches) : 
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Before and After Treatment: 
 
 RIGHT LEFT 
 BEFORE AFTER BEFORE AFTER 
Knee Joint 
Ankle Joint 
Wrist Joint 
Elbow joint 
Index finger 
Middle finger 
Ring finger 
Little finger 
    
 
EXAMINATION OF OTHER SYSTEMS: 
1. Respiratory system  : 
2. Cardio Vascular system : 
3. Gastro Intestinal system : 
4. Central Nervous system : 
DAILY PROGRESS 
 
 
DATE 
 
SYMPTOMS 
 
DRUG 
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GOVERNMENT SIDDHA MEDIDCAL COLLEGE HOSPITAL, 
POST GRADUATE RESEARCH CENTRE, 
PALAYAMKOTTAI, TIRUNELVELI-627 002 
BRANCH – III SIRAPPU MARUTHUVAM. 
ADMISSION-DISCHARGE SHEET FOR “AZHALKEEL VAYU” 
 
IP No   :    Occupation : 
Bed No  :    Income : 
Ward   :    Nationality : 
Name   :    Religion : 
Age   :    Date of Admission : 
Sex   :    Date of Discharge : 
Permanent Address:    Diagnosis : 
       Result : 
Temporary Address:    Medical officer : 
CLINICAL PICTURES 
Sl.No. During Admission During Discharge 
   
 
PLACE: 
DATE:      Signature of Medical Officer. 
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P L E 1/2 1 P L E 1/2 1
1 Muthammal 655 62 F 02.03.07 23.03.07 9,600 68 28 4 30 65 68 9,400 64 34 2 15 32 68 72 25 150 N N NAD N N NAD N N Rt. OA 22 Par. Imp
2 Mahamayi 791 55 F 20.03.07 09.04.07 8,100 60 31 9 3 8 71 8,100 60 36 4 2 5 70 89 21 160 N N NAD N N NAD N N Bil. OA 21 Improved
3 Sudalai 793 75 M 20.03.07 12.04.07 9,000 52 38 10 20 45 72 9,100 56 38 6 15 25 70 75 31 159 N N NAD N N NAD N N Bil. OA 24 Par. Imp
4 Samuvel 828 62 M 25.03.07 20.04.07 9,200 64 34 2 2 5 74 9,200 58 38 4 2 5 75 80 17 158 N N NAD N N NAD N N Bil. OA 26 Improved
5 Muthuvel 874 42 M 31.03.07 04.05.07 9,600 64 32 4 3 7 67 9,600 64 34 2 2 5 70 71 19 147 N N NAD N N NAD N N Bil. OA 35 Improved
6 Swaminathan 912 60 M 05.04.07 01.05.07 9,800 70 28 2 15 32 69 9,600 68 28 4 12 25 70 60 32 194 N N NAD N N NAD N N Bil. OA 27 Improved
7 Lakshmi 918 60 F 06.04.07 06.05.07 9,200 64 32 4 3 7 78 9,400 63 34 3 3 7 75 70 17 151 N N FEC N N NAD N N Bil. OA 31 Improved
8 Sankarammal 932 55 F 07.04.07 26.04.07 9,400 60 36 4 15 32 75 9,400 64 34 2 15 32 75 98 21 150 N N NAD N N NAD N N Bil. OA 20 Par. Imp
9 Xavier 1060 65 M 21.04.07 04.06.07 9,600 63 36 1 3 7 75 9,400 64 34 2 3 7 75 84 38 147 N N NAD N N NAD N N Bil. OA 45 Improved
10 Parvathy 1068 60 F 21.04.07 11.05.07 7,900 56 34 10 30 55 41 8,000 56 38 6 15 32 48 70 23 150 N N FEC N N NAD N N Bil. OA 21 Par. Imp
11 Ramasamy 1410 78 M 26.05.07 20.06.07 9,400 68 28 4 20 52 68 9,400 64 34 2 15 32 68 85 28 165 N N FEC N N FEC N N Lt. OA 26 Par. Imp
12 Pandian 2254 70 M 06.09.07 08.10.07 9,000 64 34 2 2 5 75 9,200 60 38 2 2 5 75 75 30 150 N N FEC N N NAD N N Bil. OA 33 Improved
13 Gnanambal 2474 73 F 05.10.07 09.11.07 8,000 60 38 2 3 7 68 8,200 64 34 2 3 4 65 146 35 243 N N FPC N N NAD N N Bil. OA 36 Improved
14 Pandithevar 2554 78 M 16.10.07 04.11.07 8,600 58 38 4 5 12 68 8,400 58 36 6 3 7 65 72 30 149 N N OPC N N OPC N N Bil. OA 20 Par. Imp
15 Vimali 2842 40 F 19.11.07 18.12.07 8,800 60 36 4 20 45 60 8,600 56 34 10 12 22 65 73 19 181 N N NAD N N NAD N N Rt. OA 30 Improved
16 Vijaya 2934 36 F 30.11.07 25.12.07 8,500 68 28 4 15 25 66 8,600 68 28 4 3 7 66 108 17 190 N N OPC N N NAD N N Rt. OA 26 Improved
17 Parameswari 2959 52 F 04.12.07 23.12.07 9,100 68 28 4 30 50 70 9,100 64 32 4 12 25 70 74 16 157 N N NAD N N NAD N N Bil. OA 20 Par. Imp
18 Lakshmi 2960 68 F 04.12.07 07.01.08 10,900 70 28 2 12 22 66 10,200 68 28 4 5 12 68 86 17 199 N N FEC N N NAD N N Bil. OA 35 Improved
19 Nambi 88 75 M 12.01.08 31.01.08 8,800 56 38 6 5 12 66 8,600 58 38 4 5 12 70 140 30 189 N N NAD N N NAD N N Bil. OA 20 Par. Imp
20 Sankarammal 123 48 F 18.01.08 07.02.08 10,100 68 30 2 15 30 72 10,000 64 34 2 12 22 70 78 18 163 N N FEC N N FEC N N Bil. OA 21 Improved
N - Nil
NADNo Abnormal Deposit
Sug
BU SC
Urine Analysis
Alb
BT AT
BS
Hb
DC %Name
Tc 
IP No ESR 
mm hrs DC %
ESR 
mm hrs
Age Sex D.O.A D.O.D
DepAlb Dep
Motion test
Tc 
Haematological Investigation
X-ray No. of Days ResultsS.No
2)   KEELVATHATHUKU  THYLAM as External Medicine for AZHAL KEEL VAYU
List of In  Patients  of PG III - Sirappu Maruthuvam Department
Given 1)  KEELVATHATHUKU CHOORANAM as Internal Medicine
EC - Epithelial Cells, PC - Pus Cells, 
BT AT
Hb Ova CystSug
S.NO Name IP NO Age Sex Wt in kg Ht in m BMI
1 Muthammal 655 62 F 55 1.51 24.1
2 Mahamayi 791 55 F 53 1.55 22
3 Sudalai 793 75 M 72 1.62 27.4
4 Samuvel 828 62 M 75 1.64 27.9
5 Muthu Vel 874 42 M 65 1.62 24.8
6 Swaminathan 912 60 M 78 1.64 29.1
7 Lakshmi 918 60 F 66 1.58 26.5
8 Sankarammal 932 55 F 65 1.56 26.7
9 Xavier 1060 65 M 64 1.66 23.2
10 Parvathy 1068 60 F 51 1.5 22.6
11 Ramasamy 1410 78 M 75 1.65 27.5
12 Pandian 2254 70 M 62 1.66 22.5
13 Gnanambal 2474 73 F 69 1.6 26.9
14 Pandithevar 2554 78 M 78 1.72 26.4
15 Vimali 2842 40 F 71 1.59 27.4
16 Vijaya 2934 36 F 56 1.58 22.4
17 Parameswari 2959 52 F 68 1.58 27.3
18 Lakshmi 2960 68 F 54 1.55 22.5
19 Nambi 88 78 M 56 1.64 20.8
20 Sankarammal 123 48 F 52 1.52 22.6
Obesity                        ‐           More than 30.
Body Mass Index of in Patients 
BMI = Weight in kg/(Height in meters)2 
Normal BMI                  ‐           In Males 20 to 24.9
                                      ‐           In Females 18 to 24.9
Overweight                  ‐           25 to 29.9
